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1 Abstract  
 
In this work, a new and efficient synthesis of 9,9-Dimethyl-bicyclo[3.3.1]nonane-2,6-dione, 
which is a potential precursor of the ABC ring skeleton of the anti-tumor drug taxol (1), has 
been synthesized by using a photochemical oxa-di-π-methane rearrangement as a key 
reaction.  
 
Taxol (1):   
OAcO
O
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H
OBzOH
OPh
OH
O
OH
NHPh
O
A
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The synthesis starts with the addition of dilithated propargyl alcohol to 2,2-
dimethylcyclohexa-1,6-dione (56). The product 57 was then subjected to a Nazarov-type 
cyclization in order to obtain the β,γ-unsaturated endione 58. Treatment with CH3OH/H2SO4, 
HOAc/H2SO4 and P2O5/CH3SO3H resulted in the decomposition of the starting compound. 
Reaction of 57 with amberlyst 15 gave, however, the expected compound 58.   
 
O O O
OH
OH
OH
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O
Amberlyst 15
HOAc  
95 oC56 57 58
nBuLi
dry THF
-78 oC  
 
Oxa-di-π-methane rearrangements, which are analogs of the di-π-methane rearrangement, are 
widely applied for the synthesis of natural products. Irradiation of 58 in the presence of 
acetophenone as sensitizer with the 350-nm light (Rayonet reactor) gave the unexpected 
product 77. Failure of this transformation has been explained by the stabilization of one of 
the possible intermediate radicals 76. The generated intermediate radical seems to be 1,3-acyl 
shift product which was stabilized by the neighboring carbonyl groups.  
 
O
O
O
O O
O
58 7776  
 
Efforts were then directed to the synthesis of another β,γ-enone so that the oxa-di-π-methane 
rearrangement would not have the intermediate like 76. For this reason, 57 was oxidized with 
Jones reagent and then hydrogenated on 10% Pd/charcoal. When the obtained cyclic lactone 
83 was treated with polyphosphoric acid (PPA) the target β,γ-endione 78 was obtained in 
60% yield. The oxa-di-π-methane rearrangement of 78 to 84 was achieved by irradiating at 
350-nm light (Rayonet reactor) and acetophenone was used as the sensitizer with a yield of 
87%.    
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The next important step of this work was the cleavage of the central cyclopropane bond of 
84. Attempts of cleavage included hydrogenation, H2SO4 in acetone, HBr in HOAc, HCl in 
HOAc, BF3·Et2O in acetic anhydride treatment. Furthermore, neighboring group participation 
to facilitate the cleavage by push-pull mechanisms, oxidative opening with Pb(OAc)4 and 
dissolving metal reduction like Birch and Bouveault-Blanc reductions have also been tried. 
Although these methods work for other compounds, they were not successful in cleaving the 
central bond of 84; either the starting material was recovered or  
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lateral bond cleaved in the cyclopropane occured. Reasons are, depent on the methodapplied, 
either the lack of sufficient orbital interaction between the carbonyls and the cyclopropane 
bond which is intended to be cleaved or the unfavorable build-up of a carbenium center at the 
α-position of the carbonyls, i.e. the propellane junction in 84.  
 
H2, 10% Pd/C
H2SO4/acetone
HBr/HOAc
HCl/HOAc
BF3.Et2O/Ac2O
anchimeric assistance with -OAc 
Pb(OAc)4
Zn/HOAc
Zn/KOH
M/EtOH or M/NH3(l)
starting material 
starting material 
cleavage of the lateral bond
cleavage of the lateral bond
cleavage of the lateral bond
starting material 
starting material 
acetylation of α-carbon
cleavage occurs but large 
excess of metal is needed
cleavage of the lateral bond
O
O
84
 
 
In order to still achieve the wanted bond cleavage in 84, potassium-graphite intercalation 
compound (C8K) was applied so that conjugation of the carbonyls and lateral bonds were not 
anymore the predominant factors for the cleavage of the cyclopropane. Similarly, a build-up 
of cationic intermediates will be avoided by this method which is known to proceed via 
diradical anions (see below). As a result, the central C-C bond in 84 was cleaved with C8K 
and 85 was obtained that is according to our synthetic plan the precursor of the ABC ring 
skeleton of the anti-tumor drug taxol (1).  
 
O
O
O
O
O
O
84
C8K 2C8K 2C8K
H
85  
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For introducing the C ring to the compound 85, one of the carbonyls of 85 was protected and 
the monoprotected ketone 135 was subsequently transformed to tert-butyldimethylsilyl enol 
ether 136. Next, ZrCl4-catalyzed [2+2] cycloadditions with but-2-ynoicacid methylester (133) 
were studied. Unfortunately, the strong oxophilic character of the catalyst renders the [2+2] 
reaction of 136 and 133 very difficult to handle and the starting materials were recovered. 
Further attempts in this direction will be undertaken in the future by handling the reaction 
under strict oxygen-free conditions (glove box under argon) since analogous transformations 
in literature sound promising in view of further attempts to carry out this transformation 
succesfully.  
 
O
O
85
O
135
O
Op-TsOH
benzene
TBDMSOTf
NEt3
CH2Cl2 136
O
O
OTBDMS2,2-dimethylpropane
-1,3-diol (134)
ZrCl4
COOMe
82 + 129
(133)
 
 
 
It should also be noted that the present approach towards 1 involves – in contrast to most 
approaches in literature – precursors containing the geminal dimethyl group which is 
ultimately very important for the biological activity of the target.    
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2 Introduction  
 
2.1  Short history 
 
Taxol (1, Figure 1) is a natural anticancer product, which is isolated from the bark of the 
pacific yew tree, Taxus brevifolia. The activity of the compound was discovered in a 
screening process initiated by the National Cancer Institute (NCI) for chemotherapeutic 
activity. As a result of this screening process Taxus brevifolia was found to be cyctotoxic to 
9KB (human oral epidermoid carcinoma) cells and P1534 leukemia cells by Wani and Wall 
who gave the name of “taxol” to this antitumor compound1. In 1971, they have also cleared 
the tetracyclic, highly oxygenated diterpene structure of taxol by obtaining the single crystal 
X-ray structure. Despite its promising activity and novel structure, initial interest in taxol was 
not great due to its scarcity, poor aqueous solubility and the lack of information about its 
mechanism of action. The discovery of taxol’s mechanism of action by Horwitz2 and finding 
the activity against B16 mouse melanoma cell3 led to increased interest in taxol. First clinical 
trials began in 1981 and demonstrated that taxol had significant activity against solid tumors 
such as ovarian cancer and breast cancer, and stimulated consequence an enormous public 
interest in the drug4,5. In 1989, Bristol-Myers Squibb was selected to commercialise taxol. 
The Food and Drug Administration (FDA) approved the use of taxol for treatment of ovarian 
cancer in 1992 and subsequently in 1994 FDA approved taxol for breast cancer 
chemotherapy. Currently it is used against a variety of tumor types, including lung, head, 
neck cancers. Also, it has activity against small cell lung cancer, oesophagel, 
gastricendometrial, bladder, germ cell tumors and AIDS-associated Kaposi’s sarcoma6.   
 
OAcO
O
OAc
H
OBzOH
OPh
OH
O
OH
NHPh
O
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B C
D
 
 
Figure 1: Structure of taxol (1) 
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2.2 Mechanism of action of taxol (1) 
 
Taxol was discovered because of its strong cytotoxicity. Because of the supply problem and 
the poor aqueous solubility, some limited testing was carried out. Taxol’s mechanism of 
action in promoting polymerization of tubulin was discovered by Horwitz in 1979.  
 
Tubulin is a heterodimeric protein, consisting of two similar but distinct subunits (the α and 
β tubulins) which are linked to each other. Microtubules are important parts of the cell being 
essential for the cell division (mitosis) and they are formed by polymerisation of α- and β-
tubulins (monomers). The first step of polymerization is the formation of heterodimers which 
come from the dimerization of one molecule of α-tubulin and one molecule of β-tubulin. For 
the microtubule polymerization, two molecules of guanosine 5’-triphosphate (GTP) and 
magnesium ions, which enhance polymerization to microtubules, are needed. Then, a 
nucleation center is formed by heterodimers for the further polymerization to form 
protofilaments which subsequently form microtubules. A normal microtubule has a diameter 
of 24 nm and is formed by 13 protofilaments (Figure 2).   
 
When a cell needs to form microtubules for cell division, the rate of formation of 
microtubules is greater than the rate of decomposition. The concentration of tubulin 
decreases until it reaches the critical concentration of tubulin, there exists an equilibrium 
between tubulin and microtubulin.7 This process is reversible for a normal cell. The role of 
taxol is to bind microtubules and stabilize them.3 Thus, the equilibrium between tubulin-
microtubulin is affected, and tubulins are converted into microtubulins irreversibly. Taxol 
decreases both the critical concentration of tubulin being necessary for polymerization 
including the induction time for polymerization8 and taxol does it either in the presence or 
absence of GTP and magnesium ion. Taxol-induced microtubulins are thinner and much 
more stable than normal microtubules. At low temperatures and after treatment with calcium, 
microtubules are depolymerized but these conditions do not affect the taxol-induced 
microtubules. Hence, taxol blocks cells, making the formation of a normal mitotic apparatus 
impossible and inhibits cell division or proceeds very slowly to bring about tumor size 
decrease. Therefore, the best explanation of the cytotoxicity of taxol bases on its ability to 
disrupt the mitotic spindle.9   
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Figure 2: Tubulin-microtubule equilibrium10: normal microtubule assembly (upper), taxol-
promoted microtubule assembly (lower) 
 
 
2.3  Chemistry of taxol (1) and structure-activity relationships (SAR) 
Taxol (1) belongs to the class of taxane diterpenoids or taxoids which are natural products. 
The taxane skeleton consists of a basic pentamenthyl[9.3.1.0]tricyclopentadecane skeleton 
and its unique numbering system is shown in Figure 3. It has mainly two differences as 
compared to other taxoids which are the N-benzoylphenylisoserine ester group at C-13 - 
known as “side chain” – and an unusual fourth ring in the form of an oxetane attached at the 
C-4,5 positions. 
 
11
15
1 2
3
8
10
12
13
14
18
9
OAcO
4
5
6
7
O
20
OAc
H
OBz
16
OH
O2'
3'
Ph
OH
1'
O
OH
NHPh
O
A
B C
D
 
 
Figure 3: Numbering system of taxol (1) 
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Figure 3: Two different 3D views11 of taxol (1)  
 
The structure of taxol (1) is quite unusual, consisting of a bridged tetracyclic skeleton with a 
β-phenylisoserine side chain and the conformation according to X-ray is called “inverted 
cup”. Its molecular formula is C47H51NO14 with the molecular weight of 853.92 g mol-1 and 
the IUPAC systematic name11c is: [2aR-[2aa,4b,4ab,6b,9a(aR*,bS*),11a,12a,12aa,12ba]]-b-
(Benzoylamino)-a-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-
2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-
7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester. 
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Interactions of drugs with their receptors are very specific and the structure-activity 
relationship (SAR) can give valuable information about the action of a drug. Consequently, 
new analogs of drugs can be designed in order to get an improved drug activity.  By 
modifying the functional groups of taxol (1), one at a time, it can be learned whether they are 
necessary for important activity of the drug.  
 
The taxol “side chain” which is essential for the activity, is highly flexible and has different 
conformations depending on the medium. Studies on structure-activity relationship12 (SAR) 
showed that side chains with a free hydroxyl group at the C-2’ position are crucial for the 
activity. For example, methylated C-2’ is more toxic than taxol itself and has an increased 
binding affinity to tubulin.13 Furthermore, replacement of the 3’-phenyl group by small alkyl 
groups like methyl, decreases the activity significantly.14 In contrast, larger groups such as 
isobutyl, improve the activity of taxol (1).  
 
In addition, opening of the “oxetane ring” eliminates the cytotoxicity of the taxol and the 
tubulin assembly activity.15 It is concluded that hydrogen bonding properties and 
rigidification of the taxol ring system by the oxetane ring stabilizes the taxol-tubulin 
complex. For example, substitution of the oxygen by sulfur decreases the activity while 
replacement of the oxetane ring by a cyclopropane increases the activity drastically.16
 
Modifications at the C-1, C-2 and C-4 positions which are at the “southern hemisphere” 
change the activity of taxol importantly. Removal of the acetoxy group from C-4 or the 
benzoate group from C-2 result in reduced activity as compared with taxol.17 Interestingly, 
the difference in activity is modulated by the position of substituents at C-2: While 2-p-
azidobenzoyltaxol is inactive, 2-m-azidobenzoyltaxol is more active than taxol.18  
 
On the other hand, SAR investigations show that modifications on the northern hemisphere 
of taxol did not result in remarkable effects concerning the activity.19 Consequently, the 
northern hemisphere of taxol does not play an important role in the binding with 
microtubules. The results of the SAR studies of taxol are summarized in Figure 4.   
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Figure 4: Some of the structure-activity relationship (SAR)10 of taxol (1) 
 
Obtaining sufficient quantities of the compound from its natural sources was one of the main 
problems in the development of taxol as an anticancer agent. Taxol only constitutes 0.01% of 
the dry weight of the inner bark of the pacific yew tree1. Since the typical 100 years old yew 
tree yields about 3 kg of bark and collection of bark kills the tree, the use of taxol from 
natural sources threatened the species with extinction. Therefore, chemical synthesis or 
bioproduction through plant tissue became an important aim for the scientists. Fortunately, it 
was discovered that 10-deacetylbaccarin III (10-DAB) (2) could be extracted from the 
needles and leaves of the European yew tree,20 Taxus baccata in approximately 0.2% yield 
with small amount of baccatin III (3) (Figure 3). 
 
OR1O
O
OAc
H
OBzOH
HO
OR2
2: 10-Deacetyl baccatin III,   R1=R2=H 
3: Baccatin III,    R1=OAc, R2=H  
4: 7-TES-Baccatin III,   R1=OAc, R2=SiEt3
 
 
Figure 5: Components for the semisynthesis of taxol (1) 
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 The availability of 10-DAB provided an accessible supply for the “semi-synthetic” strategies 
by synthesizing the side chain21. There are many semi-synthetic approaches to taxol (1) from 
10-deacetyl baccatin III (2) and one of these strategies22 includes coupling of the protected 
side chain N-benzoyl-O(1-ethoxyethyl)-3-phenylisoserine (5) and 7-triethylsilyl baccatin III 
(4) which is the form of modified 10-DAB (2). This semi-synthetic route is applied by 
Bristol-Myers Squibb and is outlined in Scheme 1.  
 
OOAc
O
OAc
H
OBzOH
O
OTES
Ph
ONHPh
O
O O
Ph OH
ONH
O
Ph
O
O
4
DPC, DMAP
2
1. Et3SiCl, 
   pyridine 
2. CH3COCl, 
   pyridine 
5 
Taxol
(1)
HCl
EtOH/H2O
6
+
 
 
Scheme 1: Semi-synthetic approach to taxol (1) 
 
2.4 Previous total syntheses of taxol (1) 
Although a “semi-synthetic” approach has the advantage of using leaves and needless which 
are renewable parts of the yew tree, harvesting and extraction of 2 from the tree material, 
however, represents a time and energy consuming problem. Thus, an intense research is 
being carried out to produce practical total syntheses of taxol (1) that would alleviate the 
supply problem. Because of its complex ring system and many chiral centers, six independent 
syntheses based on very lengthy accesses have been achieved to date by: Nicolaou (1994), 
Holton (1994), Danishefsky (1995), Wender (1997), Kuwajima (1998) and Mukaiyama 
(1999).  
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Nicolaou has chosen a convergent approach23 (Scheme 2) in which rings A and C were 
constructed separately and then brought together to form the 8-membered B ring. Both A and 
B ring fragments were synthesized via the Diels-Alder reaction. For the regiochemistry of the 
C ring fragment 12, two reaction partners, i.e. 10 and 11, were temporarily tethered as the 
boronate and then decomplexed to aldehyde 12.  
 
OR
CNCl
OR
NNHSO2Ar
O
O
OH
OEt
O
TPSO
O
O
OBn
O
+
+
7 8 9
10 11 12  
 
Scheme 2: Nicolaou approach, synthesis of A and B ring fragments 
 
One of the key steps in Nicolaou’s synthesis is the Shapiro coupling of 9 and 12 that brings 
A and B ring fragments together. This coupling rendered 13 which is the reactant of another 
key step, a McMurry cyclization to construct the ABC skeleton 14 (Scheme 3).  
 
TBSO TPSO
O
O
OBn
OH
H
O
O
OBn
H
OO
O
O
O
19   +   12
13 14  
 
Scheme 3: Construction of the ABC rings 
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After McMurry coupling, the oxatane ring was formed. Later in the synthesis, the C-13 
oxygen was introduced by chromium-mediated allylic oxidation, followed by stereospecific 
reduction of the enone. Coupling with the ß-lactam side chain gave taxol (1) in a total yield 
of 0,01% from commercially available materials. 
 
Holton’s approach to taxol is linear24 (Scheme 4) which is different from that of Nicolaou. 
The strategy of the total synthesis relies on the ring enlargement of the natural product β-
patchoulene oxide (15) to construct the AB ring system 17 by using an epoxy to alcohol 
fragmentation including protection. Then 17 was elaborated to the ABC system 19 through 
intermediate 18. After the final elaboration of D ring and functional group manipulations, 
baccatin III (3) was synthesized.   
 
Introduction of the “side chain” was managed by coupling of 3 with β-lactam 20, followed by 
further desilylation. Taxol (1) was synthesized by this route in a yield of 0.1% from 
commercially available starting materials.  
 
 
OSiEt3
O OH
TESO
O
TESO
OTES
TESO O
OTES
TESO
O
OBOM
O
OOH
O O
O
OTMS
N
O
Ph OTES
Bz
15 16 17
3
Taxol 
(1)
20
1819  
 
Scheme 4: Holton’s synthetic route to taxol (1) 
 
 
 13 
 
 
Danishefsky’s convergent approach25 is the only one to start with a preformed oxetane ring 
(Scheme 5). The reason for this success was having a benzyl ether rather than an acetate. For 
the synthesis of CD ring moiety, Wieland-Miescher ketone (21) was used as starting material. 
 
After fragmentation (21 → 22) the A ring fragment 23 was introduced to construct the A-CD 
part 24. Cyclization to the ABCD skeleton was achieved via intramolecular Heck reaction 
(→ 25). After manipulating the functional groups, 24 was converted to baccatin III (3) which 
is a potential precursor of taxol (1). The total synthesis was completed by coupling of the β-
lactam 20, adopting the conditions that have been developed by Ojima before.  
 
            
O
O O
OBz
OTBsMeO
MeO
Li
OTMS
CN
O
O
OBz
OTBS
OH
OMeMeO
O
OTBS
O O
O
O
OBz
DH H
H
21 22
23
24
Baccatin III 
      (3)
25
20Taxol 
  (1) 
A C
 
 
Scheme 5: Danishefsky’s strategy 
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Wender reported26 the shortest total synthesis of taxol (1) to date (Scheme 6). This synthesis 
uses verbone (26) as starting material, 26 being an air oxidation by-product of pinene and it 
supplies 10 of the 20 carbons of the taxol skeleton. Fragmentation of epoxy alcohol 15 
resulted in 28 which constitutes a fully functionalised AB system. Formation of the C ring 
was achieved via aldol condensation of 28 that was elaborated at the C-3 position before. 
After bromination of C-5, osmylation of C-4 and C-20, the oxetane ring was constructed, 
followed by acylation of C-4. After synthesis of 10-deacetylbaccatin III, taxol (1) has been 
reached by employing the β–lactam coupling reactions used before. The overall synthesis has 
37 steps from the starting verbone (26).  
  
  
O
OTBS
O
O
OH
AcO
RO
O
OH
OBOM
O
OBz
AcO
RO
O
OH
4
5 OBOM
20OBz
OHAcO
RO
O
Br
OTroc
O O
O
OH
OH HH
282726
2930
Taxol 
(1)
A
B
 
 
Scheme 6: Wender’s strategy 
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Kuwajima has followed a convergent route27 to 1 (Scheme 7) like Nicolaou and Danishefsky. 
By a coupling reaction of the optically pure A ring hydroxy aldehyde 31 with the aromatic C- 
ring fragment 32 followed by Lewis acid-mediated eight-membered B ring cyclization gave 
the desired ABC skeleton 34. The former fragment 31 has been synthesized from propargyl 
alcohol in sixteen steps and the latter fragment 32 is derived from 2-bromo-2-cyclohexenone 
in eight steps. Before introducing the oxetane moiety, C-8 of 35 was methylated via 
cyclopropanation and reductive cleavage of cyclopropyl ketone. In order to osmylate the C 
ring for attachment of the oxetane ring, steric congestion around the A cycle of the taxol 
skeleton increased by acetylation of C-10. Since these steps - introduction of methyl to C-8 
and formation of oxetane ring - needed exchange of the protecting groups, the synthetic route 
became rather lengthy. Finally, acylation of the C-13 by the β-lactam and removing the 
protecting groups completed the total synthesis.  
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Scheme 7: Kuwajima’s strategy 
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Mukaiyama reported the final synthesis28 in 1999 (Scheme 8). Unlike other strategies, a 
unique pathway starting from an 8-membered ring compound by way of B to BC to ABC to 
ABCD ring construction achieved the total synthesis of taxol (1). Compound 39 has been 
converted to the B ring equivalent 40 via aldol cyclization. Although 8-membered ring 
compounds are not easily available directly from simple linear precursors, this high yielding 
cyclization proceeds smoothly because the linear precursor having suitable conformations for 
cyclization. The C ring was introduced via Michael addition and intramolecular aldol 
cyclization to 40. Construction of the ABC ring system was achieved by way of allylation of 
C-1 and an intramolecular pinacol coupling reaction of 41. The oxetane ring was finally 
introduced via allylic bromination, osmylation and ultimately the addition of the side chain 
has completed the total synthesis.  
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Scheme 8: Mukaiyama’s strategy 
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2.5  Biosynthetic studies  
In addition to total taxol syntheses, alternative sources for taxol production are vigorously 
searched for due to the long reaction sequences and low yields of the hitherto synthetic 
approaches and the required substantial effort for purification of semi-synthesis precursors 
from plant tissue and separation of the desired intermediates. Improvement of the 
biosynthetic process based on the understanding of the pathway for taxol formation, i.e. the 
enzymes an their mechanism of action and the structural gene encoding of these enzymes. To 
date several investigations have been done for the biosynthetic approach of taxol.  
 
The taxol biosynthetic way consists of approximately 20 enzymatic steps and it has been 
shown29 that cytochrome P450 enzymes responsible for oxygenation, hydroxylation and 
acetylation. However, the intermediate steps of the taxol biosynthetic pathway remain 
undefined and are under investigation. The route to taxol (1) starts with the cyclization of the 
diterpenoid precursor geranylgeranyldiphosphate (44) to taxa-4(5),11(12)diene (45) by 
taxadiene synthase (Scheme 9). Then 45 is hydroxylated to taxa-4(20),11(12)-dien-5α-ol (46) 
by cyctochrome P450 taxadiene 5α-hydroxylase. 46 is subsequently converted to taxa-
4(20),11(12)-dien-5α-yl acetate (47) by taxa-4(20),11(12)-dien-5α-ol-O-acetyltransferase. 
Hydroxylation of 47 by cyctochrome P450 taxane 10β-hydroxylase gives 48 that is converted 
to 49 via yet undefined steps. Taxane-2α-O-benzoyltransferase converts 49 into 10-
deacetylbaccatin III (2) that is acetylated by 10-deacetylbaccatin III-10-O-acetyltransferase to 
render baccatin III (3).  
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Scheme 9: Biosynthetic pathways to taxol 
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2.6  Objectives 
 
The aim of this work was to synthesize precursors en route to a synthesis of the anti-tumor 
drug taxol (1) skeleton. Primarily structures of types C and D should be approached as an 
entry to the basic ABC ring skeleton of 1. The envisaged synthetic strategy, which is the 
result of a retrosynthetic analysis (see Scheme 10, p. 21 and structures below) includes two 
key steps that are step (a) a photochemical oxa-di-π-methane (ODPM) rearrangement of β,γ-
unsaturated cyclic dienone structures of type A to afford the propellane-type cyclopropyl 
ketone B. This intermediate should beneficially contain the characteristic geminal dimethyl 
pattern being seemingly important for the biological activity of 1. A second important step 
(b) will involve the cleavage of the central cyclopropane bond of the propylene B (→ C) for a 
proper set-up of the AB ring moiety.  
 
O
O
O
A
B CA BA
A B C D  
 
Although the total synthesis of 1 has been achieved six times before, none of these 
approaches is efficient and the synthetic routes are lengthy. The shortest route consists of 37 
steps (synthesis by Wender et al.24). At present, the anti-tumor drug taxol (1) is obtained 
semi-synthetically by harvesting the leaves of the European yew tree (taxus baccata) and 
extracting the 10-deacetylbaccarin III (10-DAB) (2) from the leaves. Since the harvesting and 
extracting consume lots of time and energy, the presently available supply of 1 is 
problematic. This work is to pioneer a shorter and efficient access of taxol (1) synthetically. 
Furthermore, the planned reaction scheme should allow to carry out a variety of functional 
modifications of intermediate precursors to enable broader biological activity testing of the 
target structures.  
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3 Results and discussion 
 
3.1  Strategy 
 
The taxane diterpenes, the main representative being taxol (1, Figure 1), stimulated a 
considerable interest from synthetic chemists because of the broad antitumor activities of this 
class of compounds and their unique structures which contain an unusual tetracyclic skeleton 
with an sp2 carbon at its bridgehead C-11 and a geminal dimethyl group at the carbon bridge 
C-15 between the A and B rings. While several approaches to the total and semi synthesis of 
taxol have been successfully carried out.30 many attempts have focused on the synthesis of 
the carbon skeleton of this diterpene.31 The synthetic approaches are yet very lengthy and 
especially the achieved total syntheses out of this reason unrealistic for practical applications.  
 
In our studies directed towards the synthesis of the basic taxol skeleton, such as 50 (see 
Scheme 10, p. 22), we planned a linear route as outlined in a retrosynthetic way. One of the 
key steps, i.e. 52 ⇒ 53, represents synthetically a photochemical transformation, the so-
called oxa-di-π-methane (ODPM) rearrangement, which involves in the present case the 
reaction of the β,γ-unsaturated enone 53 to 52. The ODPM rearrangement of β,γ-enones was 
successfully applied to the synthesis of natural products32 in the presence of other functional 
groups that are not affected under irradiation. This photochemical key step is thought to be a 
short entry to achieve a synthetic access to the bicyclic 51 and the tricyclic 50 on the way to 
1. To make the photochemical key step possible we should have a short access to the enone 
53 which is planned along the retrosynthetic line 53 ⇒ 54 ⇒ 55.  
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Figure 7: Structure of taxol (1) 
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Scheme 10: Retrosynthetic route to the basic taxol-like skeleton 50 
 
 
3.2  Synthesis of 2,2-dimethylbicyclo[4.3.0]non-1(6)-en-3,9-dione (58) 
 
The retrosynthetic analysis of the diterpene skeleton 50 (Scheme 10) shows how the 
envisaged ODPM rearrangement strategy (53 → 52) relies on the access to the β,γ-enone 53 
or an analog thereof. The first step of the reaction sequence for the synthesis of 58 (Scheme 
11), which is a carbonyl analog of 53, starts with dimethylation33 of the commercially 
available cyclohexan-1,3-dione (55). Afterwards, dilithated propargyl alcohol was added to 
56 at –78 ºC to give 57 in 54% yield.34 For the synthesis of the target β,γ-endione 58, a 
Nazarov-like cyclization was applied to 57.  
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Scheme 11: Synthesis of 58 from 55 
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To accomplish this Nazarov-type cyclization, acidic catalysts such as CH3OH/H2SO4,35 
2 4HOAc/H SO 36 and P2 5 3 3O /CH SO H33c,37 were applied which, however, resulted in 
decomposition of the starting material.  Only the treatment with an acidic ion exchange resin, 
amberlyst 15 in HOAc, gave34,32c,  38 58 from 57, although in a low yield of 13%. The 
suggested mechanism of this transformation is depicted in Scheme 12.                                                              
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Scheme 12: The proposed reaction mechanism of the Nazarov-like cyclization 57 → 58 
 
Cyclization of divinyl ketones to yield cyclopentenones is called Nazarov cyclization. 59 → 
58 is a typical Nazarov cyclization. 59 is the precursor to form the cyclic cationic 
intermediate 59b on the way to 58 via the acyclic precursor 59a. In addition, acetylenic diols 
can be transformed to five-membered cyclic adducts. In case of the cyclization of compound 
57, 59 is formed in situ by treating 57 with acidic ion exchange resin amberlyst 15 which 
implies the intermediacy of the vinylic cation 57a and its rearranged isomer 57b on the way 
to 59 via 57c.  
 
 
3.3  Oxa-di-π-methane (ODPM) rearrangements 
 
Photochemical 1,2- and 1,3-acyl sigmatropic shifts of β,γ-enones represent an important class 
of reactions that are often used to achieve skeletal transformations in total synthesis of 
natural products. The 1,2-acyl shift is commonly known as the oxa-di-π-methane (ODPM) 
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rearrangement since it is structurally and mechanistically analogous to the di-π-methane 
rearrangement.39 In principle, β,γ-enones can undergo photoreactions such as, cis-trans 
isomerization,40 [2+2] cycloaddition,41 reduction,42 decarbonylation,43 etc. depending on the 
structure of the enone. However, reactions of the β,γ-unsaturated ketones are dominated by 
two main transformations, the 1,3-acyl shift and the ODPM rearrangement. In general, direct 
irradiation of β,γ-unsaturated ketones yield44 1,3-shifts, whereas ODPM rearrangements 
occur with triplet sensitized energy transfer. The former offers the isomerization of the enone 
(e.g. 60 → 61), the latter results in the formation of cyclopropyl ketones45 of type 62 
(Scheme 13).  
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Scheme 13: 1,3-acyl shift (→ 61) and ODPM rearrangement (→ 62) from 60 
 
The ODPM rearrangement includes formally a 1,2-acyl migration followed by 
cyclization.39,44 In detail, the biradical intermediate 63a is the primary intermediate of 63 
which undergoes ring opening to 63b being a very short-lived 1,3-biradical which 
recombines to form the final cyclopropyl ketone 64 (Scheme 14). The alternative ring 
opening of the biradical intermediate 63a that would yield the even shorter-lived oxirane 63c 
has never been observed.  
O O O O
O
O
63 63a 63b 64
63c 65  
 
Scheme 14: General reaction mechanism of the oxa-di-π-methane (ODPM) rearrangement 
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On the other hand, two competitive routes have been proposed for the 1,3-acyl shift.38,44 The 
first route is a fragmentation-recombination mechanism involving a single intermediate stage 
corresponding to a free radical pair 66a which forms the final isomerization product 67 
(Scheme 15). The second route is called the quasi-concerted process via the two feasible 
biradical intermediates 66b which can be either a tight intermediate or a loose intermediate 
radical pair. In the first description of the intermediate, all C-C bonds are formed and in the 
second one, the radical pair is held together as a loose radical contact pair.   
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Scheme 15: The reaction mechanism of the 1,3-acyl shift43
 
The reaction mechanisms of the ODPM rearrangement and the 1,3-acyl shift have been 
studied and the excited-state reactivity and correlation has been established.32,46 Generally, 
1,3-acyl shifts can take place from the singlet excited state (S1, nπ*) via direct irradiation, 
whereas the oxa-di-π-methane rearrangement occurs from the lowest triplet excited state (T1, 
ππ*) in the presence of a sensitizer47 (Figure 8). During irradiation, the excited state energy 
of a sensitizer, such as acetophenone, benzophenone or acetone, is transmitted to the β,γ-
enone in the ground state which finally ends up in its lowest triplet state T1 (π-π*). It should 
be pointed out that the sensitizer must have sufficient triplet energy to excite the triplet (T1) 
state of the β,γ-unsaturated ketone in an exothermic energy transfer process in order to enable 
the ODPM rearrangement.  
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Additional investigations provided more detailed information about the excited state-
reactivity correlations of β,γ-unsaturated ketones. The intersystem crossing from the singlet 
to the triplet state populates generally the higher triplet state (T2, ππ*) and, if the life time 
allows, 1,3-acyl shifts can also occur from this state. However, this represents a very rare 
process.32,46  
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Figure 8: Jablonsky diagram of the oxa-di-π-methane rearrangement vs. the 1,3- acyl shift  
followed by rearrangement46
 
ODPM rearrangements give good to excellent yields, especially in case of the semicyclic, 
bicyclic and bridged β,γ-unsaturated ketones.39b,48  The efficiency and the limits strongly 
depend on the conformational flexibility of the β,γ-enone moiety. For higher chemical yields, 
rigid structures of reactants are favorable in view of orbital overlap and inhibition of energy 
decay from the excited state(s) by internal conversion. The bridged, bi- and tricyclic enones 
exhibit such rigid structures and indeed afford ODPM rearrangements with high yields. For 
example, photochemical reactions of a variety of bicyclo[2.2.2]octenones have been 
studied.49 Irradiation of 68 in the presence of acetone as the sensitizer gives the ODPM 
rearrangement products, the tricyclooctanones 70 with excellent yields up to 86% (Scheme 
16).  Notably, there is no scrambling of substituents observed upon this rearrangement in 
general.  In the absence of a sensitizer the cyclobutanones 69 are obtained. 
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Scheme 16: 1,3-Acyl shift vs. ODPM rearrangement of the conformationally rigid 
bicyclic enone 68 
 
In order to provide sufficient rigidity in acyclic enones, the carbon between alkene and the 
carbonyl group of a β,γ-enone must be fully substituted by alkyl, phenyl or vinyl moieties. 
Otherwise, other channels of energetic deactivation of the triplet state predominate, such as 
cis-trans isomerization. This form of energy dissipation50 is called “free-rotor effect.” One 
example for this kind of process is shown in Scheme 17. Irradiation of 72 in the presence of a 
sensitizer results in cis-trans isomerization of 71 and 72, without formation of an ODPM 
product (e.g. 73).   
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Scheme 17: Free-rotor effect: cis-trans isomerization of 71 
 
Besides that, additional conjugation of chromophores at either the ketonic or the olefinic part 
as well as intramolecularly competitive electronic effects have been examined.46 n general, 
reactants that have chromophores like A and B (Figure 9) need a sensitizer for the ODPM 
rearrangement, while reactants having chromophores like C and D undergo ODPM 
rearrangements upon direct irradiation via intersystem crossing from the singlet state (S1, 
nπ*) to the triplet excited state (T1, ππ*). Furthermore, ODPM reactions occur exceptionally 
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from the higher singlet excited state (S2, nπ*) which is exemplified by a β,γ-enone that 
carries a phenyl moiety.  
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Figure 9: Chromophore conjugations: A and B undergo ODPM rearrangements in the 
presence of a sensitizer, C and D give low yield ODPM rearrangements 
without sensitizer 
 
 
3.4 Photorearrangements of 58 and 78 
 
3.4.1  Attempted ODPM rearrangement of 58 
 
 The β,γ-endione 58 (for the retrosynthetic route, see chapter 3.2, p. 22) served as the starting 
compound for the planned photochemical rearrangement.31 Irradiation of 58 (Scheme 18) in 
the presence of acetophenone as sensitizer with 350-nm light (Rayonet reactor) gave a 
product showing NMR data not being compatible with the expected 9,9-dimethyl 
tricyclo[3.3.1.01,5]nonan-2,6-dione (75). Finally, the reaction product was assigned as 5-
isopropylenespiro[3.4]octan-1,6-dione (77) according to 1H, 13C and the two-dimentional 
NMR spectra. The unsymmetric signals in the 1H NMR and the existence of olefinic carbons 
in the 13C NMR spectra proved the structure of the product 77. Besides 77, starting material 
58 was recovered in 16% yield. According to the anticipated ODPM rearrangement 
mechanism, two possible diradical intermediates (74 and 76a/b) can be formulated. The lack 
of the expected product 75 via 74 can be explained by the stabilization of the radical 
intermediate 76a by the neighboring carbonyl group. This stabilization renders this biradical 
energetically more favorable. Thus, instead of the expected product 75, the spirocyclic 
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compound 77 was obtained as a result of cyclobutane cleavage in 76a. Alternatively, the 
rearrangement 58 → 77 could be formulated as a 1,3-acyl shift via 76b.  
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Scheme 18: The proposed reaction mechanisms of the photoreaction of 58 to  
75 (not formed) and 77 
     
 
3.4.2 Successful ODPM rearrangement of 78 
 
After the failure of the ODPM rearrangement of 58 to 75, the synthetic route was modified 
and 2,2-dimethylbicyclo[4.3.0]non-1(6)-en-3,7-dione (78) was synthesized (Scheme 19) to 
probe its photochemistry which is assumed to differ significantly from that of 58. With 
compound 57 in hand (Scheme 11, p. 22), we have converted it into carboxylic acid 54 via 
Jones oxidation51 in a yield of 65% along with 56 (18% yield).  
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Scheme 19: Jones oxidation of 57 
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On the other hand, the carboxylic acid 54 can be synthesized directly from 2,2-
dimethylcyclohexan-1,3-dione (56) by adding dilithated propylate 79 (Scheme 20), adopting 
the reaction conditions for 56 → 57. However, a longer reaction time is needed in this latter 
procedure giving 54 in a slightly lower yield (59%).  
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Scheme 20: Direct synthesis of 54 from 56 by addition of dilithated propargilic acid (79) 
 
The adduct 54 was then subjected to catalytic hydrogenation52 without further purification to 
synthesize lactone 83 in an overall yield of 41% from 56. When the hydrogenation reaction 
time was shortened, spirolactone 83 was obtained besides the unsaturated lactone 82. This 
means that the reaction proceeds via hydrogenation of the triple bond (→ 80) followed by 
cyclization to 82 which upon further hydrogenation leads to 83. Two olefinic doublets at  
6.11 and 7.40 ppm in the 1H NMR and –CH signals at 122.27 and 156.08 ppm in the 13C 
NMR confirm the intermediacy of 82.   
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Scheme 21: Hydrogenation of 54 
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 Spirolactones in general undergo rearrangement in the presence of strong acids.37 For the 
synthesis of the endione 78 as substrate for the planned alternative ODPM rearrangement, 
cyclic lactone 83 was treated with concentrated acid which is either polyphosphoric acid53 
(PPA) or Eaton’s reagent54 (P2O5/MeSO3H). As a result of these treatments, product 78 was 
obtained in yields of 60% and 40%, respectively. The anticipated reaction mechanism is 
shown in Scheme 22. Upon opening of the spirolactone 83 carbenium ion 83a is formed prior 
to elimination to 83b which undergoes cyclization/elimination to afford ultimately the 
desired mixed endione 78.  
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Scheme 22:  Rearrangement of spirolactone 83 to the mixed endione 78 
 
After the synthesis of 78, its ODPM rearrangement was explored. As mentioned before, β,γ-
enones can undergo under certain circumstances ODPM rearrangements without sensitizer. 
However, such rearrangements under these excitation conditions are real exceptions. 
Although the compound 78 has a chromophore being further conjugated with the β,γ-enone 
moiety, the previous studies in our laboratories show that irradiation55 of 78 without 
sensitizator gave the expected product 84 (Scheme 23), albeit in 8% yield only. During the 
attempts to increase the yield in different solvents and in the presence of sensitizaters, 40% 
yield of ODPM product was achieved when the reaction was run in acetonitrile and 
acetophenone was added as sensitizer. Moreover, by increasing the reaction time to 30 hours, 
the product yield increased up to 88%. Irradiation of the reaction mixture was studied by 
using a Rayonet equipment with λmax = 350 nm. The likely mechanism of the photochemical  
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 transformation of 78 → 84 is depicted in Scheme 23. After energy transfer from 
acetophenone to the α,β- and β,γ- unsaturated ketone 78, biradical 78a is generated and it 
rearranges to the cyclopropyl diketone 84 via recombination of the radical centers in 78b. 
Notably, the spirocyclic product 77 did not form here.    
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Scheme 23:  ODPM rearrangement of the endione 78 to 84 via the biradical 
intermediates 78a,b 
 
 
3.5  Attempts to cleave the central C-C bond of 84 
 
In the studies directed towards the photochemical construction of the basic carbon skeleton of 
taxol (1), we have synthesized successfully the key intermediate 9,9-
dimethyltricyclo[3.3.1.01,5]nonan-2,6-dione (84) via an ODPM rearrangement from 2,2-
bicyclo[4.3.0]non-1(6)-en-3,7-dione 78 in excellent yield, and expected then to be able to 
open the central C-1,5 bond of this propellane product so that we can obtain 
bicyclo[3.3.1]nonan-2,6-dione 85 as a potential precursor of the AB rings of the taxol 
skeleton (→ 51).  
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Scheme 24: Planned route to a precursor (85) of the AB rings of the taxol skeleton 51 
 
Cyclopropane, the smallest cycloalkane, is highly strained and has bond angles of 60°, far 
away from the 109.5° angle that sp3-hybridized carbons normally adopt. Because of the bond 
angle compression it is seen that orbitals overlap neither head to head like in σ bonds nor 
laterally like in π bonds. Thus, bonds are in between σ and π bonding, called “bent bonding”. 
The result is that the carbon-carbon bonds are weaker than those having normal bond angles 
and hence cyclopropanes are much more reactive than other cycloalkanes. Controlled 
cleavage of cyclopropane intermediates provides a useful method and has been successfully 
employed in the synthesis of multicyclic natural products. 
 
60o
bent 
bonding
 
 
Figure 10: Bent-bonding and the interaction of σ and π orbitals of the cyclopropane 
 
 
3.5.1 Hydrogenation of 84 
 
Hydrogenation56 of cyclopropane is one of the ways to cleave this strained cyclic compound. 
It has been shown that hydrogenation of cyclopropane derivatives usually results in the 
preferential cleavage of the least substituted ring bonds.57 For the ring opening insertion of 
the catalyst, such as palladium, is needed, i.e. the steric effect plays a most important role. 
9,9-dimethyltricyclo[3.3.1.01,5]nonan-2,6-dione (84) should be an excellent candidate for 
such a cleavage with its C2 symmetry with a fully substituted cyclopropane. However, the 
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geminal dimethyl group at C-9 and the two five-membered rings seemingly protect this 
substrate against hydrogenation so efficiently from either side that no hydrogenation of the 
cyclopropane was found and complete recovery of starting material was the result when 
hydrogenation was carried out with 10% Pd/C in ethyl acetate.      
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Scheme 25: Hydrogenation attempt of cyclopropyl diketone 84 
 
 
3.5.2 Acid-catalyzed treatment of 84  
 
In addition to the catalytic hydrogenation of cyclopropanes, acid-catalyzed reactions are 
used58 for opening of cyclopropane rings. For example, H2SO4/acetone was used as the 
cleaving agent for 86 in our laboratories effectively59 (Scheme 26). But the same conditions 
applied to 84 led only to the recovery of the starting material.  
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Scheme 26: Previous cyclopropyl opening (86 → 87) and application of the same 
procedure to 84  
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Furthermore, electrophilic reagents were used for the cleavage of conjugated cyclopropyl 
ketones. 84 was treated with halogenic acids60 (HCl or HBr) in acetic acid at reflux 
temperature and two compounds were obtained. The yield was increased up to 80% by using 
tetrachloromethane as solvent at room temperature. One of them was identified as 78 
(structure, see p. 32) by its NMR analysis, whereas the other one shows NMR and mass 
spectral data not being compatible with the expected ring opening compounds 88a/88b 
(Scheme 27). 400 MHz 1H, 13C NMR and IR spectra of these products fit however the 
structures for the halogenated compounds 89a/89b. Both, the chlorinated and the brominated 
compound exhibit NMR spectra having doublets of doublets at 3.15 and 3.19 ppm, 
respectively. In addition, in the 13C NMR spectrum the existence of two quaternary and one –
CH carbons are compatible with the proposed structures 89a/89b. In order to make sure that 
we have obtained 89a and 89b instead of the expected 88a and 88b, these halogenated 
products were subjected to dehalogenation by catalytic hydrogenation and Bu3SnH. 
Unfortunately, the product does not show the NMR data being characteristic for 85, but the 
existence of a quartet in the 1H NMR showing the coupling of two identical methyl groups 
with –CH together with an unsymmetric 13C NMR spectrum showing that the unexpected 
product 90 was obtained. These data were completed with mass spectral information to 
ensure that 89a/89b were formed as a result of exclusive lateral bond cleavage of the 
cyclopropane. 
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Scheme  27: Treatment of 84 with HCl/HOAc and HBr/HOAc 
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A reasonable mechanism for the acid-catalyzed opening of a cyclopropyl ketone involves 
initial protonation of the carbonyl group (→ 91), followed by ring opening (→ 92) to yield 
the halogenated diketones 89a and 89b. In theory, ring cleavage in the tricyclic diketone can 
yield two different bicyclic skeletons by either cleavage of central (→ 93) or the lateral (→ 
92) bonds (Scheme 28). There are some reasons for the failure of the central bond cleavage. 
It is well known that formation of carbocations are difficult or impossible at bridgehead 
positions where they cannot be planar, i.e. adapt sp2 configuration.  Additionally, formation 
of bridgehead carbocations is possible only with large rings or in adamantane. Furthermore, 
the formation of a carbocation at α-carbons of carbonyls renders the intermediate 
energetically unfavorable.   
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89a, X=Cl  
89b, X=Br
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Scheme 28: Anticipated reaction mechanism for the formation of 89a and 89b from 84 
 
Besides the developing carbocationic character, direction of cleavage of the cyclopropyl 
ketones is controlled by geometrical factors. As mentioned before, cyclopropanes have bent- 
bonds that have characteristics between σ and π bonds. These bent-bonds have in the present 
case delocalization with the π orbitals of the carbonyl groups. Owing to the geometry of the 
 36 
 
 
ring system, the central carbon-carbon bond does not overlap largely with the π system of the 
carbonyl groups, whereas the lateral bond has excellent overlap. Thus, the cyclopropane bond 
with greatest overlap with the carbonyls cleaves preferentially, i.e. 84 → 92 in Scheme 28 
and Figure 11.   
O
O
 
 
Figure 11: Interaction of orbitals of the carbonyl and the lateral bonds of the       
cyclopropane in 84 
 
The side product 78 is likely the result of carbocation rearrangement in 92 to form the 
α,β;β,γ- endione 78 after proton loss from 94 (Scheme 29). Interestingly, the acid-catalyzed 
re-formation of 78 from 84 constitutes overall a thermal retrosynthetic process (in cationic 
intermediate steps) of the photochemical ODPM rearrangement 78 → 84 (Scheme 23).  
 
O
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O
O
O
H O
-H+
92 94 78  
 
Scheme 29: Rearrangement of the carbocation 92 to the α,β;β,γ-unsaturated endione 78 
 
 
3.5.3 Reaction of 84 with borontrifluoride-etherate  
 
Borontrifluoride-etherate (BF3·Et2O) was reported61 to cleavage a cyclopropane being 
conjugated with a carbonyl group to give an enolacetate. Cyclopropyl diketone 84 was 
treated with BF3·Et2O at –78 °C under an argon atmosphere (Scheme 30). Unfortunately, the 
opening proceeded in the same mode of as seen before with acid catalysis to give 96 with a 
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yield of 62% instead of central bond cleavage. Besides 96, compound 78 was formed again 
(15%).  
 
O
OAc
O
O
O
OAc
OAc
AcO
BF3/Ac2O
95 9684  
 
Scheme 30: Borontrifluoride-etherate treatment of the cyclopropyl diketone 84 
 
 
3.5.4 Attempt to cleave the central bond of 98 by the aid of anchimeric assistance 
 
Since the propellane bond in 84 is not sufficiently activated for cleavage as outlined before, 
we decided to replace one carbonyl by an acetyl function. By this way, the intermediate 
carbocation is hoped to be stabilized via anchimeric assistance62 by the acetyl so that 
cleavage of the central bond might be facilitated. The replacement of a carbonyl with acetyl 
was achieved in two steps, that are reduction of the carbonyl to the alcohol 97 by NaBH4 and 
esterification to 98 (Scheme 31).  
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O O O
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X OAc
AcOHO
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HX 
HOAc
84 97 98
99100101  
 
Scheme 31: Attempt of the cleavage of the central bond in 98 with the aid of anchimeric      
assistance by the –OAc group in 99 
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The ability of oxygen to assist in the intramolecular departure of leaving groups is a classical 
example of neighboring group participation. The lone pair on oxygen serves as the 
nucleophile and provides the electrons to form e.g. a Prévost-type intermediate such as 99. 
We hoped that the reaction would result with nucleophilic opening of the three-membered 
ring and 100 and/or 101 would form (Scheme 31). Unfortunately, this attempt resulted in 
four compounds that were isolated and identified. It is seen that ring cleavage of a the lateral 
bond of the cyclopropyl ketone took again place and 102 formed as the main product in 27% 
yield indicating that the reaction follows the same path as with 84: Lateral cleavage of the 
cyclopropane and addition of chloride (→ 102, 105) or rearrangement of the carbocationic 
intermediate (→103, 104).  
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Scheme 32: Reaction of 98 with HCl in HOAc 
 
 
3.5.5 Treatment of 84 with the lead tetraacetate  
 
Oxidative cleavage of cyclopropanes by lead tetraacetate (Pb(OAc)4) yields generally 
diacetates63a,b (107, 108, 111) or mono(un)saturated62a,64 acetates (109, 113) (Scheme 33). 
This reaction has been found to be applicable not only for alkyl and aryl cyclopropanes but 
also for cyclopropyl ketones.65 On the other hand, it has been reported64 that the treatment of 
carbonyl compounds with lead tetraacetate results in α-acetoxy ketones with the preference 
of less substituted α-carbons and also it was affirmed that enolization of the ketone is a 
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required intermediate in the formation of acetoxy ketones (Scheme 33). It might be 
reasonable to expect the formation of bridgehead-substituted or unsaturated 
bicyclo[3.3.1]nonan-2,6-dione (85) derivatives when  84 was reacted with lead tetraacetate 
(Scheme 34).  
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106 107 108 109
110 111
112 113  
 
Scheme 33: Some examples of opening of cyclopropyl ketones with Pb(OAc)4 
 
Treatment of 84 with Pb(OAc)4 in boiling or ice-cold acetic acid/benzene afforded a major 
(115) and a minor product (116) in yields of 53% and 16%, respectively. When the mol ratio 
of lead tetraacetate was increased to 5, with respect to 84, 115 was obtained as the major 
product with a yield of 25% and 116 was the minor product with 8% yield. A plausible 
mechanism includes displacement of the carbonyl oxygen with acetate ion resulting in the 
enol intermediate 114 which then rearranges to the products 115 and 116.  
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Scheme 34: Reaction mechanism of 84 with the Pb(OAc)4
 
In summary, all attempts that included catalytic hydrogenation, acid-catalyzed reactions 
including, reactions with borontrifluoride-etherate, acid-catalyzed reactions with neighboring 
group participation by an acetate and reactions with lead tetraacetate in order to cleave the 
central carbon-carbon bond of compound 84 failed. There are some reasons for the failure. 
First of all, the fully substituted cyclopropane such as in compound 84 is stericaly heavily 
hindered against reagent additions from any side. The cyclopropane is protected from the 
upper side by the geminal dimethyl groups and from downside by the five-membered rings. 
In addition to this and as mentioned before, the propellane bond of the cyclopropane to be 
cleaved is the one that ought to have sufficient conjugation with the π orbitals of carbonyl 
groups. It must be considered that the lateral bonds fulfill these conditions more satisfactorily 
than the central bond does. 
 
 
3.5.6 Dissolving metal reduction  
 
After all these unsuccessful attempts to cleave the central bond in 84, it was decided to try 
dissolving metal reduction which are known from literature to reduce α,β-enones as well as 
cyclopropyl ketones efficiently. However, again sufficient orbital interaction is required 
between the chromophoric parts of the substrate to be reduced.  
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One of the earliest reduction procedures is the treatment of such chromophores with active 
metals either in the presence of a proton donor, which is the reaction medium itself, or 
followed by treatment with a proton donor.66 Mostly alkali metals, mainly lithium, sodium, 
potassium and also zinc, calcium, magnesium are utilized. The dissolving metal reductions 
include electron transfer from the metal surface or from the metal in solution to the substrate.  
 
The generally accepted mechanism66 for dissolving metal reduction of enones involves 
reversible addition of an electron to a vacant orbital of the substrate (S), yielding a radical 
anion (S-.). The latter can be protonated to give a neutral radical which may either dimerize or 
accept another electron and a proton. Also, stepwise or simultaneous reversible addition of 
two electrons to S can give a dianion capable of accepting two protons.  
 
S S -
S 2 -
H +
H +
HS
HS -
HS
H +
HS-SH
HSH
+ e -
- e -
+2 e -
-2 e -
- e -
+ e - e 
-
 
 
Scheme 35: Reaction mechanism of dissolving metal reduction of an α,β-enone  
as substrate (S) 
 
 
3.5.6.1 Treatment of 84 with zinc  
 
In acetic acid or in ethanol solution of potassium hydroxide, zinc can transfer electrons to the 
substrate. For example, conjugated 1,4-enedione systems generate67 a radical dianion which 
leads to formation of a saturated dione. In addition, treatment of γ-diketones with zinc in 
acetic acid results68 in cleavage of the α,β-carbon bond in the four-membered ring. The 
conversion of 117 to 118 is a good example for such kind of cleavage reactions (Scheme 36). 
Unfortunately, the reaction of 84 with zinc in acetic acid or with potassium hydroxide in 
ethanol resulted with complete recovery of the starting material. Moreover, increase of the 
reaction time and temperature did not change the result.  
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Scheme 36: Conversion of diketone 117 to 118 
 
 
3.5.6.2 Birch and Bouveault-Blanc reduction of 84 
 
Another type of dissolving metal reductions69 is the Birch reduction70 (Li or Na in liquid 
ammonia) and Bouveault-Blanc reduction69 (Li or Na in alcohol). The treatment of 84 with 
excess lithium in ammonia gave the pinacol 9,9-dimethyltricyclo[3.3.12,6.01,5]non-1,5-diol 
(123) in 60% yield besides a trace of 85 (Scheme 37) which constituted a first but rather 
limited success in these efforts. Hence, the compound 85 was generated during the reaction. 
Bouveault-Blanc reaction of 84 (Na in ethanol or isopropanol/toluene) led exclusively to the 
pinacol 123. By using a large excess of Na with respect to 84, the reaction yield increased up 
to 80%. Cleavage of the pinacol 123 was achieved by lead tetraacetate treatment and the 
target product 85 was synthesized successfully in 55% yield. Birch reduction and Bouveault-
Blanc reduction, both have the same mechanism to crack the cyclopropane conjugated with 
the carbonyl groups. As it is seen in Scheme 37, the reaction starts with electron transfer and 
diketyl forms. After the cleavage of the central bond, the intermediate diradical abstracts 
protons from the solvent and pinacol 123 is produced. Lead tetraacetate is widely used71 to 
cleave pinacols and indeed application of this oxidation process to 123 resulted smoothly in 
the formation of the expected diketone 85 (yield of the overall process 84 → 85: 44%).  
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Scheme 37: Reaction mechanism of cleavage of the central bond of 84 by using  
Birch and Bouveault-Blanc reactions (→ 123) 
 
 
3.5.6.3 Treatment of 84 with potassium-graphite (C8K) 
 
A further attempt to transform 84 directly to 85 was finally successful by application of the 
following method of reduction. Potassium-graphite-intercalated compounds72 into C8K is 
widely used as method to reduce organic compounds. Graphite has a lamellar structure and 
appears in nature in two forms: hexagonal and rhombohedral. The most stable form is 
hexagonal having a layer stacking sequence of ABABA-- with an interlayer distance of 3.35 
Å and the layers are not superimposable. Rhombohedral graphite has a layer sequence of 
ABCABC-- stacking where every third layer is superimposable. This form exists rarely and it 
is not used as a host material for the synthesis of graphite-intercalated compounds.  
 
Electronically, graphite is a semimetal73. Bonding between carbon atoms involves sp2-
hybridized orbitals. The structure of graphite shows the voids between the planar sp2-
hybridized carbon sheets. Intercalation is achieved by the insertion of ions, atoms or 
molecules into this space without destruction of the host-layered bonding network. Bond 
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distance and stacking order may be altered but the carbon layers of the graphite remain 
undistorted after the intercalation that is, the planar hexagonal structure is preserved.  
 
The graphite is called the host and the ingested compound is called intercalant, which is 
classified as donor or acceptor according to whether it gives electrons to graphite or abstracts 
electrons from the host.72 The known electron donor intercalants are alkali metals including 
Li, K, Rb, Cs and alkaline earth metals such as Ba, Ca, St as well as transition metals as Eu, 
Yb. The most widely used electron acceptor intercalants are FeCl3. Br2, HNO3, AsF5.  
 
The stage of intercalation is the ratio of host layer (graphite) to guest layers (potassium).72 
Depending on the conditions of the preparations, the stages may be obtained from 1 to 8.   
When higher temperature/pressure is applied, higher stages of potassium graphite-
intercalation are obtained.74 Since the carbon hexagons do not superimpose in two 
neighboring planes in pure graphite, these planes stack in ABAB configuration. In the first 
stage (C8K), planes stack in A/A/A configuration and it is the most concentrated one because 
of highly filled interlayer voids. In the second stage (C24K), the stacking sequence is 
AB/BC/CA/AB and the stacking sequence for the third stage (C36K) is ABA/ACA/ABA.73  
 
First stage 
C8K C24K
Second stage 
C36K
Third stage
a b c
 
 
Figure 4: Sequences of carbon () and potassium (●) layers :  
a) C8K, b) C24K, c) C36K 
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Figure 12: Structure of the C8K intercalate a) three-dimension view b) unit cell 
 
The presence of potassium atoms in the graphite influences the reactivity of 4s electrons and 
there is a reversible fast electron transfer from the 4s electrons to the π system of the 
graphite.75 The substrate is absorbed at the surface of C8K and electrons are transferred from 
the edge of it.72 Potassium-graphite was used73 for Wurtz reactions, reduction of α,β-
unsaturated carbonyls and alkyl halides, hydrogenation, polymerization and reduction of 
polycyclic hydrocarbons.   
 
The reducing agent potassium-graphite (C8K) was applied to compound 84 for the cleavage 
of the central bond. C8K was synthesized76 by adding freshly cut potassium (very important; 
note that old potassium can lead to explosion and fire under the given reaction conditions) to 
vigorously stirred graphite at 160 ºC under an argon atmosphere. After cooling to room 
temperature, bronze-colored laminate compound of the intercalation medium C8K was 
formed. Addition of the substrate 84 was completed in dry THF via syringe at room 
temperature. The reaction takes 5-6 days, in case of a shorter reaction time the yield 
decreases. In addition, treatment with old potassium also decreases the reaction yield. The 
reduction of 84 must have the same or at least similar mechanism as the Birch reduction: The 
anticipated mechanism for this reaction is outlined in Scheme 38. The initial step involves 
electron transfer from the edge of the potassium-graphite intercalation material to diketone 84 
to generate a dianion radical 124. Rearrangement of 124 gives the enolate anions via 
homolytic cleavage of the central bond (→ 125). By proton abstraction from the solvent, 
being dry THF, compound 85 is obtained.  
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Scheme 38: Reaction mechanism of cleavage of the central bond of 84 with potassium-
graphite intercalated medium (C8K) 
 
 
3.6 Attempts of ring enlargement in 85 
 
After the cleavage of the central bond of 84, the next target was to synthesize a compound 
having a structure like bicyclo[5.3.1]undecene (51) which is a potential precursor of the AB- 
ring part of taxane (Scheme 39).  
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Scheme 39: AB rings of the skeleton of taxol (1) 
 
The required ring enlargement can be managed by formation of a cyclobutene, followed by 
fragmentation of this small ring. It has been reported77 that ZrCl4-catalyzed [2+2] 
cycloaddition of ethyl propiolate (127) to tert-butyldimethylsilyl enol ether 126 results in the 
cyclobutene esters 128 and 129 (Scheme 40). ZrCl4 was dissolved in the reaction mixture by 
adding Et2O to the reaction solvent CH2Cl2 in 10:1 ratio.  Actually, the catalyst ZrCl4 is not 
soluble in apolar solvents. Addition of oxygen-containing solvents, like Et2O or THF, 
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provides the solubility of the catalyst by coordination to the ZrCl4. In addition, it was noted 
that when acetyl dicarboxylate was used, no cyclobutene was formed.77  
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Scheme 40: ZrCl4-catalyzed [2+2] reaction of 126 with ethyl propionate 127 
 
Since 85 and 126 have similar structures, 85 was converted to the silylenol ether 132 
(Scheme 41). For this reason, one of the carbonyls was protected by using 1,2-ethanediol 
(130) as the protecting reagent. The monoprotected compound 131 was obtained78 with 65% 
yield in the presence of p-toluenesulfonic acid as catalyst by refluxing in a Dean-Stark 
apparatus. After that, ketone 131 was transformed into the tert-butyldimethylsilyl enolether 
132 in quantitative yield by treatment with tert-butyldimethylsilyltriflate (TBDMSOTf).77    
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Scheme 41: Monoprotection of 84 as tert-butyldimethylsilyl enol ether 132 via 131 
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 The silylenol ether 132 was then treated with ZrCl4 and methyl but-2-ynoate (133) at –78 ºC 
(Scheme 42). Unfortunately, this attempt of ZrCl4-catalyzed [2+2] reaction77 of 132 and 133 
failed. Compounds 85 and 131 were recovered with 45 and 41% yield, respectively.  
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Scheme 42: ZrCl4-catalyzed [2+2] reaction of 132 and methyl but-2-ynoate (133) 
 
The reason of this failure might be the steric hindrance of the 5-membered protecting group 
towards the reduction medium. For that reason, another protecting group, 2,2-
dimethylpropane-1,3-diol (134) which is conformationally more flexible than the previous 
one, was used77 (Scheme 43). This protection yielded 135 in 61%. After treatment of 135 
with TBDMSOTf in the presence of NEt3, the enolether 136 was obtained in quantitative 
yield. 
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Scheme 43: ZrCl4-catalyzed [2+2] reaction of enolether 136 with 133 
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Application of the previously applied procedure to the silylenol ether 136 with methyl but-2-
ynoate (133) in presence of ZrCl4 gave unfortunately back 85 and 135. The failure of the 
ZrCl4-catalyzed [2+2] cycloaddition of 132 and 136 can be explained by the oxophilic 
character of the catalyst. Since ZrCl4 has not any electron at the d orbitals, it is very oxophilic 
and interacts with any oxygen-containing compound very easily. If there is even a trace 
amount of air or water in the reaction medium the catalyst turns to ZrOCl2 and HCl. As a 
result, the acetal and enolether functions of 132 and 136 reform 85 and the monoprotected 
diketones 131 and 135, respectively. Due to the oxophilic character of ZrCl4, the [2+2] 
cycloaddition of 132 and 136 should be studied in the future under a strictly moisture- and 
oxygen-free argon atmosphere in a glove box.  
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4 Outlook 
 
The future prospects of this work consist of mainly two parts: The first part involves the 
cleavage of central bond of 84 and the ring enlargement which starts with the ZrCl4- 
catalyzed [2+2] reaction of 136 and but-2-ynoicacid methylester (133) in the glove box. As 
mentioned previously, the oxophilic character of ZrCl4 makes it very sensitive to even trace 
amounts of water and oxygen. After the synthesis of the [2+2] adduct 137, the cyclobutene 
moiety should be rearranged77 to give 138 by heating 137 with HBF4 in EtOH. The C ring of 
the taxol skeleton is planned to be introduced via Michael addition79 (138 → 140) and 
treatment with HCl (→ 141). The addition of 139 to 138 should preferentially occur from 
downside (→ 140). 
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This addition of 139 to 138 is essential for obtaining the correct ring junction geometry in 
view of the ABC-ring assembly related to the taxane target structure. In order to be able to 
predict the outcome of this addition, quantum mechanical calculations (geometry 
optimization) of 138 were performed.  
 
Geometry optimizations were performed employing density functional theory.80 The pure BP 
function was used,81 in combination with SV(P) basis sets.82 For all calculations, the 
TURBOMOLE program83 package was used and the calculations were performed for 
vacuum conditions. Furthermore, only charge neutral systems were investigated. The 
structures were plotted employing gopenmol84 (Figure 14).  
 
Indeed an addition of 139 on the underside of 138 seems to be sterically less hindered as 
compared to a top side attack. The geminal dimethyl group is seemingly shielding the latter 
side efficiently enough. As a result, the correct relative configuration of the C-8 methyl 
should  be obtained.  
 
 
 
 
Figure 14: Optimized geometry of 138. Left: South view, Right: North view. Modelling 
performed in collaboration with Dr. S. Sinnecker 
   (Max Planck Institute for Bioinorganic Chemistry) 
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 A modification of this future approach could involve first the ring enlargement and then the 
cleavage of the central bond. For the ring enlargement, the known procedure for the ZrCl4-
catalyzed [2+2] cycloaddition reaction will be applied (142 → 143). The advantage of this 
second part is the mild cleavage of the cyclopropane and the introduction of a bridgehead 
double bond (144 → 145) which will allow further functionalizations. 144 will be treated 
with Nafion-TMS85 for the cyclopropane opening including the elimination step. The C ring 
of the taxol skeleton will be introduced via Michael addition79 (→ 146) and treatment with 
HCl (→ 147), a reaction sequence which was described before. The stereochemical outcome 
of this sequences should be analogous to the one described for 138 → 140 → 141.  
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Another geometry optimization has been performed for the compound 145. As mentioned 
before, the relative configuration of the methyl at C-8 is important. In order to provide that 
Michael addition (145 → 146) will be achieved on the underside of 145 the geometry 
optimization, which was studied for 138, was performed also for 145. The result of density 
functional theory (Figure 15) shows that dienolate 139 again add to 145 on the underside 
because of more steric interactions to be expected on the top side.                                                                     
 
 
 
 
Figure 15: Optimized geometry of 145 Left: South view, Right: North view. Modelling 
 
performed in collaboration with Dr. S. Sinnecker (Max Planck Institute for 
Bioinorganic Chemistry) 
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 A last but important point should concern studies regarding the introduction of chirality into 
our synthetic approach. A likely solution could involve the monoacetalization step on 84 or 
85 using a C2-symmetrical reagent like optically active tartrate (148) or butane-2,3-diol (149) 
to give e.g. 150 as chiral building block.  
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5 Experimental section 
would like to thank to following co-workers of the Max Planck Institute for Bioinorganic 
would like to thank to Dr. Sebastian Sinnecker of our institute especially for the DFT 
.1 Instruments, methods and materials 
elting points (Mp):  
rt or Kofler apparatus and are uncorrected.  
ltraviolet absorption spectra (UV):  
ins Omega-10 spectrometer. λmax values are given in 
nfrared spectra (IR):  
sed plates using Brucker IFS 66 (FT-IR-Spectrometer) or a Perkin-
Mass spectra (MS):  
 MAT 311A or MAT 95 (HRMS) instruments at 70 eV ionization 
 
I 
Chemistry and the Max Planck Institute for Coal Research for their most valuable services: 
Mrs. K. Sand and Mr. J. Bitter (NMR spectra); Mr. W. Schmoeller and Mr. W. Joppek (MS 
spectra). My appreciation is also extended to all the members of the administration, library 
staff and technical staff of the Max Planck Institute for Bioinorganic Chemistry, whose 
assistance has made the completion of this work both possible and enjoyable. 
 
I 
calculations and geometry optimizations. 
 
 
5
 
M
Determined on a Reiche
 
U
Recorded with either a Carry 17 or Bru
nm; ε values in parantheses.  
 
I
Recorded with KBr-pres
Elmer 1600 instrument. Frequency values are given in cm-1. The symbols s (strong), m 
(medium) and w (weak) characterize the relative band intensities.  
 
Recorded on Finnigan
energy. Data are presented in m/z values. When required, molecular ion peaks were 
ascertained by chemical ionisation (CI) or fast atom bombardment (FAB) techniques.  
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Nuclear Magnetic Resonance spectra (NMR): 
lowing Brucker instruments: An ARX-250 
hin layer chromatography (TLC):  
ica gel plates (F254, Merck). As developing reagent, a 
olumn chromatography:  
pressure variants on self-packed Kronlab Sepakron-FPGC glass 
rradiation:  
ere stirred and flushed with argon prior to use. Cylindrical Pyrex reaction 
olvents:  
from Merck, Aldrich or Fluka and used directly or purified by standard 
eagents: The chemical name, abbreviated molecular formula (with parantheses, if 
Recorded in Fourier Transform mode on the fol
(250 MHz for 1H, 63 MHz for 13C), an AM-400 (400 MHz for 1H, 100.6 MHz for 13C) and a 
DRX-500 (500 MHz for 1H, 125.8 MHz for 13C) with dilute solutions in deuteriochloroform 
(CDCl3) at 300 K unless stated otherwise. The chemical shift values are given in δ units 
(ppm, parts per million) with trimethyl silane as internal standard. All coupling constants, J, 
are reported in Hz. The multiplicity of a signal is designated by one of the following 
abbreviations: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), and br (broad).  
 
T
Performed on 0.20 mm (aluminium) sil
solution containing 30 g vanillin, 5 ml conc. H2SO4 and 1000 ml EtOH. The plates were 
visualized with UV light and then thermally developed.  
 
C
Gravimetric columns or high 
columns of different sizes on Merck silica gel 60 (0.063-0.20 mm or 0.04-0.063 mm) with 
pressure pump Buechi 688 or Besta E-100 and pressure 1-10 bar were used; all solvents were 
distilled before use. 
 
I
All samples w
vessels, equipped with cooling fingers (H2O coolant), were used. Rayonet reactors (RPR-
208-System, Southern New England Ultraviolet company) with sixteen 350 nm (λmax) lamps 
(24 watt/lamps) were employed for irradiation.   
 
S
Purchased 
procedures. Absolute solvents were purchased from Fluka and kept on molecular sieves.  
 
R
appropriate), quality, purification procedure and company of purchase are listed below.  
Acetic acid (HOAc): z.S., Merck 
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Acetic anhydride: 95%, Merck 
Acetophenone: 99%, Fluka 
Amberlyst 15: 99%, Fluka 
2,2’-Azobisisobutyronitrile (AIBN): 98 %, Aldrich 
ntent of 46.5-49.5%, Fluka 
): 99%, Fluka 
99%, Fluka  
Fluka 
uka 
a 
: 99%, Fluka 
 Fluka 
 (NaHCO3): 99%, Merck 
SOTf): 98%, Aldrich 
%, Aldrich 
: 98%, Fluka 
n-Butyl lithium (n-BuLi): 1.6 M in n-hexane, Fluka 
Boron trifluoride diethyl etherate (BF3·Et2O): BF3 co
But-2-ynoate : 99%, Acros 
Chromium (VI) oxide (CrO3
1,3-Cyclohexadione 97%, Fluka 
1,2-Ethanediol: 99%, Merck 
Graphite: 99%, Fluka 
Methyl iodide (CH3I): 
Lead tetraacetate (Pb(OAc)4): 95%, 
Lithium (Li): 99%, Fluka 
10% Pd-Charcoal: 99%, Fl
Polyphosphoric acid: 84%, Fluk
Potassium (K): 99%, Fluka 
Potassium carbonate (K2CO3)
Propargyl alcohol: 99%, Fluka 
Propylic acid: 96%, Across 
Pyridine: 99%, Fluka 
5% Pt-Charcoal: 99%,
Sodium (Na): 99%, Fluka 
Sodium hydrogencarbonate
Sodium boronhydride (NaBH4): 96%, Aldrich  
Sulphuric acid (H2SO4): z.S., Merck 
tert-Butyldimethylsilyltriflate (TBDM
Triethylamine (NEt3): 99%, Merck 
Tri-n-butyltin hydride (Bu3SnH): 97
Toluene-p- sulphonic acid monohydrate (PTSA)
Zirconium tetrachloride (ZrCl4): 99%, Aldrich  
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5.2 Nomenclature and general synthetic and photochemical procedures  
omenclature:  Compounds have been named according to the standard nomenclature rules 
eneral synthetic procedures: A cold bath of –78 °C was prepared from a mixture of 
.3 Reactions 
.3.1 Synthesis of 56 
o a stirred solution of 1,3-cyclohexandione (55) (25 g, 0.223 mol) and acetone (200 ml) was 
,2-Dimethylcyclohexane-1,3-dione (56): 
S (EI; m/z, rel. int.):  
12O2), 97 (100), 70 (83), 67 (37), 55 (70), 42 (79), 41 (48). 
 
N
(IUPAC) by means of the program AUTONOM, with the exception that the numbering 
system has in some cases been chosen more conveniently with respect to NMR signal 
assignments.  
 
G
acetone and dry ice. Oxygen or moisture sensitive reactions were performed under an argon 
flow in either oven- or heat-gun-dried glassware equipped with rubber septa. Air or moisture 
sensitive liquids or solutions were transferred through a funnel under a rapid argon flow. 
“Concentration” involved drying of the combined organic layers over anhydrous Na2SO4, 
filtration and solvent removal by roto-evaporation and high vacuum (10-1-10-3 torr). 
“Chromatography” refers to column separation technique performed on Merck silica gel 60 
(0.063-0.20 mm; 100 fold), unless stated otherwise, giving product purities of >97%.     
 
 
5
 
5
 
T
added anhydrous K2CO3 (90 g, 0.70 mol) at 50 ºC. The reaction mixture was refluxed for 15 
hours and then cooled to room temperature. Afterwards the resulting mixture was filtered and 
the filtrate was concentrated. Chromatography of the crude product on a flash column of 
silica gel with pentane-ether (1:1) gave 2,2-dimethylcyclohexane-1,3-dione (56) with 55% 
yield (23.9 g).  
 5
2
1
O O
2
 
M
140 (49.37, M+, C8H
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HRMS  I; m/z):  
or C8H12O2: 140.083730; found: 140.083877. 
 
(250 MHz): 2.64 (t, J=6.66 Hz, 4H); 1.9 (m, 2H); 1.26 (s, 6H).  
C NMR (63 MHz, BB, DEPT, 1H; 13C-COSY): 
37.18 (CH2, C-4,6); 22.05 (CH3, C-7,8); 
IR  Br):  
 2941w 1727m, 1695m, 1383m 
 
.3.2 Synthesis of 3-Hydroxy-3-(3-hydroxy-prop-1-ynyl)-2,2-dimethyl-cyclohexanone 
 
 solution of propargylalcohol (95%, Fluka, 1,40 g, 25 mmol) in 140 ml dry THF was 
-Hydroxy-3-(3-hydroxy-prop-1-ynyl)- 
(EI; m/z, rel. int.):  
O3), 178 (6), 163 (28), 150 (9), (36), 
(E
calculated f
1H NMR 
 
13
210.28 (Cq, C-1,3); 61.55 (Cq, C-2); 
17.86 (CH2, C-5). 
 
(K
2966w, , 
5
(57) 
A
cooled to –78 °C under stirring and argon atmosphere. To this solution was added dropwise 
34.4 ml (55 mmol) of an n-BuLi solution (1.6 M in hexane, Aldrich) during 20 min. The 
resulting mixture was stirred for further 2 hours, then a solution of 2,2-dimethylcyclohexan-
1,3-dione (56, 2.8 g, 20 mmol) in dry THF (20 ml) was added dropwise, before stirring for 
further 8 hours. 100 ml of water was then added and the mixture slowly warmed to room 
temperature. The organic phase was separated and the aqueous phase extracted with ether 
followed by drying of the combined organic layers over anhydrous sodium sulfate. After 
evaporation of the solvent, the residue was chromatographed on a flash column of silica gel 
with pentane-ether (1:1) to give product 57 2.04 g (54%) as a white solid.  
 
3
2
5
1
O 7
9
OH
OH2,2-dimethyl-cyclohexanone (57): 
 
MS 
196 (8.2, M+, C11H16 135 (18), 122 (13), 111  
98 (100), 93 (16), 86 (41), 83 (19), 70 (21), 65 (31), 55 (37), 41 (38).  
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HRMS I; m/z):  
or C11H16O3: 196.109945; found: 196.109824. 
 
H NMR (400 MHz):  
2C-9); 4.1 (br. s, 1H, HOC-9); 3.87 (s, 1H, HOC-3); 2.35-2.23 (br. 
 
C NMR (100.6 MHz, BB, DEPT, 1H; 13C-COSY): 
8); 75.28 (Cq, C-3); 53.53 (Cq, 
Mp 42.0-44.0 °C. 
R (KBr):  
3303s (br.), 1698s, 1468w, 1451w, 1426w, 1383w, 1365w, 
5.3.3 Synthesis of 7,7-Dimethyl-3,4,5,7-tetrahydro-2H-indene-1,6-dione (58) 
7 (2.02 g, 10.3 mol) was dissolved in 10 ml acetic acid and 1.01 g amberlyst 15 (Acros) 
,7-Dimethyl-3,4,5,7-tetrahydro- 
(E
calculated f
 1
4.15 (s, 2H, H
m, 2H); 2.08-1.71 (br. m, 4H); 1.14 (s, 3H, CH3); 1.08 (s, 3H, CH3).  
13
214.26 (Cq, C-1); 85.84 (Cq, C-7); 83.86 (Cq, C-
C-2); 50.12 (CH2, C-9); 36.20 (CH2, C-2); 33.99 (CH2, C-4); 22.17 (CH3); 19.93 
(CH2, C-5); 19.07 (CH3). 
 
 
I
3588m, 3499w, 
1349w, 1176w, 1127m, 1018s, 991w, 960m. 
 
 
5
added to this solution, then stirred at 95 °C for 20 hours.The amberlyst 15 was filtered off 
and the filtrate distilled in vacuo to remove acetic acid before the residue was dissolved in 
ethylacetate, washed with a saturated solution of sodium hydrogencarbonate and the organic 
phase was thereafter concentrated in vacuo and the residue chromatographed on silica gel 
with pentan-ether (1:2). The product 58 was obtained as a dark yellow solid in 13.6% yield 
(0,25 g).  
 
6
O
8
1
O
4 3
7
2H-indene-1,6-dione (58): 
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HRMS (EI; m/z):  
or C11H14O2: 178.099553; found: 178.099381. 
MS I; m/z, rel. int.):  
O2), 150 (33), 136 (100), 135 (74), 121 (53), 107 (16), 93  
 
 (250 MHz):  
 4H, CH2); 2.53-2.43 (m, 4H, CH2); 1.33 (s, 6H, CH3). 
 
C NMR (63 MHz, BB, DEPT, 1H; 13C-COSY): 
9.72 (Cq, C-7); 143.92 (Cq, C-9); 44.34   
Mp  °C.  
R (KBr):  
br.), 2956s, 2869w, 1740s, 1720m, 1643s. 
.3.4 Photochemical reaction of 7,7-Dimethyl-3,4,5,7-tetrahydro-2H-indene-1,6-dione 
 
 a cylindrical Pyrex irradiation vessel, equipped with a cooling finger, 58 (88.5 mg, 0.497 
-Isopropylidene-spiro[3.4]octane-1,6-dione (77): 
calculated f
 
(E
178 (95, M+, C11H14
(43),  91 (24), 79 (21), 77 (21). 
1H NMR 
2.69-2.61 (m,
13
213.56 (Cq, C-6); 207.15 (Cq, C-1); 16
(Cq, C-7); 36.20 (CH2); 34.61 (CH2); 28.92 (CH2); 27.94, (CH2); 22.86 (CH3, C-
10, 11).  
 
75-76 
 
I
 3465m (
 
5
(58) (→ 77) 
In
mmol) was dissolved in 140 ml acetonitrile and degassed under stirring for 1 hour before 
irradiation at room temperature for 40 hours. The reaction mixture was irradiated in a 
photochemical chamber reactor (type Rayonet RPR-208), equipped with 8 lamps (each 24 W, 
RUL 350 nm, λmax = 350 nm, emission range 300-400nm). After evaporation of the solvent, 
the residue was chromatographed on silica gel with pentane-ether (1:2) to give the product 77 
(55.1 mg, 62.3%) as a colorless oil besides a second fraction of 14.4 mg (16.3%) of 58.  
 
4
9
6
O
1
O
3
5
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MS (EI; m/z, rel. int.):  
O2), 150 (96), 136 (100), 135 (82), 121 (95), 107 (24), 93 
HRMS /z):  
or C11H14O2: 178.099380; found: 178.099614. 
1H NMR (400 MHz): 
, 2H, CH2); 2.22 (s, 3H, CH3); 2.40-2.05 (m, 6H); 1.77 (s, 3H, CH3).  
C NMR   (100.6 MHz, BB, DEPT, 1H; 13C-COSY):  
1 (Cq, C-9); 133.05 (Cq, C-5); 70.90 
IR 
br.), 2961w, 1776s, 1707s, 1619m, 1437w, 1276w, 1194w, 1112w, 
 
.3.5 Synthesis of (1-hydroxy-2,2-dimethyl-3-oxo-cyclohexyl)-propynoic acid (54) 
 
) To a solution of 1.91 g (9.73 mmol) of 57 in 16 ml acetone was added dropwise a solution 
) To a solution of 1.47 g (20 mmol) propylic acid (96%, Across) in 100 ml dry THF were 
178 (22, M+, C11H14
(83), 91 (39), 80 (32), 79 (49), 77 (33), 39 (23).  
 
(EI; m
 calculated f
 
 
  3.22-3.08 (m
 
13
212.43 (Cq, C-1); 204.82 (Cq, C-6); 152.5
(Cq, C-4); 42.97 (CH2); 37.70 (CH2); 32.04 (CH2); 26.52 (CH2); 25.86 (CH3); 
21.62 (CH3).  
 
(KBr):  
3448s (
1072w. 
5
from either 57 (a) or directly from 56 (b) 
(a
of Jones reagent (mixture of CrO3 (1.946 g, 19.46 mmol), 10 ml water and 1.56 ml 97-98% 
H2SO4) at 0 °C (ice bath) during 8 hours, then stirred for further 5 hours, extracted with ether 
and the combined organic layers washed with brine and dried over sodium sulfate. After the 
evaporation of the solvent, the crude product was chromatographed on silica gel with 
pentane/ether/acetic acid (1:1:0.1) to give the product 54 in white crystalline form (1.32 g, 
64.5%) and 56 (0.25 g, 18.4%).  
 
(b
added 16 ml (40 mmol) n-BuLi solution (2.5 M in n-hexane) dropwise under argon and 
stirring at –78 °C, followed by stirring of the resulting solution at the same temperature for 
 63 
 
 
another 2 hours. Afterwards a solution of 56 (2.8 g, 20 mmol) in 20 ml dry THF was added 
dropwise and the mixture was stirred still at the same temperature for 7 days (monitoring of 
the reaction by TLC). 100 ml of water were then added slowly by allowing the reaction 
mixture to warm to room temperature. The organic phase was separated and the water layer 
acidified with dilute HCl and extracted with ethyl acetate. After the combined organic layers 
were dried over anhydrous Na2SO4, and the solvent evaporated at reduced pressure in order 
to concentrate the crude product which was purified on silica gel with pentane:ether:acetic 
acid (1:1:0.1) to give 54 in 59% yield (2.47 g).  
 
(1-Hydroxy-2,2-dimethyl-3-oxo-cyclohexyl)- 
S  (EI; m/z, rel. int.):  
14O4), 192 (10), 166 (13), 150 (26), 149 (22), 105 (16), 98 
 
RMS   (EI; m/z): 
for C11H14O4: 210.089208; found: 210.089249. 
 
 (400 MHz, CD3OD):  
; 2.60-1.85 (m, 6H); 1.29 (s, 3H, CH3); 1.23 (s, 3H, CH3).  
 
C NMR (100.6 MHz, BB, DEPT, 1H; 13C-COSY, CD3OD):  
-7); 74.79 (Cq, C-8); 53.02   
Mp 153-155 °C. 
R (KBr):  
957s, 2605s, 2246m, 1707s, 1678s, 1470m, 1425m, 1368s, 1244s. 
3
O
1
7
OH
9
O
5
OHpropynoic acid (54): 
 
 
M
210 (21, M+, C11H
(100), 91 (22), 86 (20), 85 (52), 70 (24), 67 (58), 55 (37), 53 (33), 43 (39), 42 
(37), 41 (54), 39 (31).  
H
 calculated 
1H NMR 
5.19 (br.s, 1H, HOC-9)
13
213.81 (Cq, C-3); 154.78 (Cq, C-9); 87.55 (Cq, C
(Cq, C-2); 36.10 (CH2, C-4); 33.40 (CH2, C-6); 22.35 (CH2, C-5); 19.65 (CH3); 
18.65 (CH3).  
 
 
I
3489s, 2
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5.3.6 Sy
arboxylic acid 54 (4.1 g, 0.19 mmol) was dissolved in 50 ml ethyl acetate and 10% Pd-
,6-Dimethyl-1-oxa-spiro[4.5]dec-3-ene-2,7-dione (82): 
S (EI; m/z, rel. int.):  
O3), 179 (18), 138 (14), 123 (19), 110 (100), 96 (35), 85 
 
RMS (EI; m/z):  
or C11H14O3: 194.094295; found:194.094013.  
Hz):  
=5.8Hz); 6.11 (d, 1H, J=5.8Hz); 2.57-2.53 (2H, m), 2.24, 2.10 (2H, 
  
MHz, BB, DEPT, 1H; 13C-COSY):  
8 (CH. C-4); 122.27 (CH, C-3); 94.33 
(Cq, C-5); 51.01 (Cq, C-6); 36.38 (CH2); 31.08 (CH2); 22.22 (CH3); 20.91 (CH2); 
18.66 (CH3). 
nthesis of 6,6-dimethyl-1-oxa-spiro[4.5]decane-2,7-dione (83) 
 
C
charcoal (0.15 g) was added in a two-necked flask which was connected to water pump and 
hydrogen-filled balloon. This mixture was evacuated at water pump pressure until evolution 
of bubbles then the valve of the hydrogen-filled balloon was opened. This process was 
repeated for several times. Then the reaction was left to react under hydrogen and was 
monitored by TLC. After completion, the catalyst was filtered off and the filtrate washed 
with saturated sodium hydrogencarbonate solution and dried over anhydrous sodium sulfate. 
After evaporation of the solvent at reduced pressure, the crude product was chromatographed 
on silica gel with pentane-ether (1:1) and spiro lactone 83 (2.65 g, 67.6%) was obtained as a 
white crystalline material. If the reaction time is shortened, the unsaturated analog 82 is 
synthesized besides the spiro lactone 83.   
 
9
6
6
7
O
3
O
2
O
 
 
M
194 (41, M+, C11H14
(160), 82 (14), 70 (17), 67 (65), 55 (27), 54 (19), 53 (16), 43 (21), 42 (28), 41 
(55), 39 (33). 27 (22).   
H
 calculated f
  
1H NMR (400 M
7.40 (d, 1H, J
m); 1.95-1.85 (2H, m); 1.17 (s, CH3); 1.06 (s, CH3).  
13C NMR (100.6 
210.59 (Cq, C-7); 171.41 (Cq, C-2); 156.0
 65 
 
 
Mp 
 
IR  
2s, 1712s, 1460m, 1384m, 1149m, 1090w, 964s, 914m, 814s. 
,6-Dimeth
ecane-2,7-dione (83): 
11H16O3
70 (14), 55 (33), 42 (21), 41 (28).   
HRMS 
; found:196.110156 
  
 (m, 5H, CH2); 1.14 (s,   
CH3); 1.12 (s; CH3).  
13C NMR 
5.77 (Cq, C-2); 91.95 (Cq, C-5); 52.74 (Cq, C-5); 36.37   
(CH2, C-8); 33.07 (CH2); 28.55 (CH2); 28.45 (CH2); 21.44 (CH3); 19.69 (CH2); 
Mp             
 
IR  Br):  
72s, 1706s, 1472m, 1388m, 1273m, 1232m, 1208s, 1179m, 1158s, 
956s. 
 
 
85-87 °C. 
(KBr):  
 2926m, 175
 
 
6 yl-1-oxa-spiro[4.5] 
6
7
O
3
O
2
O
9
d
 
MS  (EI; m/z, rel. int.):  
196 (57, M+, C ), 178 (5), 168 (12), 126 (15), 111 (100), 98 (17), 83 (15), 
 
 (EI; m/z):  
calculated for C11H16O3: 196.109945
 
1H NMR (400 MHz):
2.8-2.4 (m, 4H, CH2); 2.25-2.20 (m, 1H, CH2); 2.05-1.76
 
(100.6 MHz, BB, DEPT, 1H; 13C-COSY):  
211.45 (Cq, C-7); 17
18.09 (CH3).  
 
97-99 °C. 
(K
2952m, 17
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5.3.7 Synthesis of 4,4-Dimethyl-2,3,6,7-tetrahydro-4H-indene-1,5-dione (78)  
ompound 83 (673 mg, 3.4 mmol) and polyphosphoric acid (75 ml) were heated at 90 °C 
 on ice, 
xtracted with ethyl acetate and dried over anhydrous sodium sulfate. After evaporation of 
:  
178 (100, M+, C11H14O2
S 
                
   
H3). 
BB, DEPT, 1H; 13C-COSY):  
(Cq, C-8); 47.25   
(Cq, C-4); 34.74 (CH2, C-6); 34.72 (CH2, C-2); 24.72 (CH2, C-7); 23.66 (CH3, C-
Mp  
 
IR Br):  
0w, 2935w, 1772w, 1735m, 1699s, 1645m, 1447w, 1390w, 1353m, 
1231w, 1175m. 
 
 
C
under stirring and argon for 50 hours, then the viscous brown mixture was poured
e
the solvent at reduced pressure, the residue was chromatographed on a silica gel column with 
pentane-ether (1:1) to give 78 as dark yellow crystals (359 mg, 58.7%).  
 
4,4-Dimethyl-2,3,6,7-tetrahydro 
-4H-indene-1,5-dione (78): 
7
5 9
1
O
O 
 
MS (EI; m/z, rel. int.)
 ), 136 (71), 135 (46), 121 (24), 93 (28), 91 (11), 79   (11).  
 
HRM (EI; m/z):  
   calculated for C11H14O2: 178.099380; found: 178.099348 
 
1H NMR (400 MHz):
2.60-2.50 (m, 6H, CH2); 2.47-2.45 (m, 2H, CH2); 1.29 (s, C
 
13C NMR (100.6 MHz, 
212.83 (Cq; C-5); 207.35 (Cq, C-1); 177.03 (Cq, C-9); 136.48 
10,11); 19.32 (CH2). 
 
56-58 °C.  
(K
3456w, 297
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5.3.8 Sy
 
ompound 78 (197 mg, 1.11 mmol) and acetophenone (1.33 g, 11.1 mmol) were dissolved in 
cetonitrile (180 ml) and placed in a cylindrical Pyrex irradiation vessel, equipped with a 
 
action mixture was irradiated in a photochemical chamber reactor (type Rayonet RPR-208), 
S (EI; m/z, rel. int.):  
8), 135 (97), 12 (27), 80 (25), 
, 39 (22).   
S 
 
(400 MHz):  
m, 2H, CH2); 2.36-2.26 (m, 4H, CH2); 2.04-1.97 (m, 2H, CH2), 1.29 
 BB, DEPT, 1H; 13C-COSY):  
-8, 9 ); 19.01 (CH2, C-3, 6).  
 
 
IR 
nthesis of 7,7-Dimethyl-tetrahydro-3a,6a-methano-pentalene-1,4-dione (84)  
C
a
cooling finger (water cooling). After degassing of the solution with argon for one hour, the
re
equipped with 8 lamps (each 24 W, RUL 350 nm, λmax= 350 nm, emission range 300-400 
nm). After irradiation for 30 hours, the solvent was evaporated in vacuo and the residue was 
chromatograped on silica gel with pentane-ether (3:1) to afford the product 84 in a yield of 
89% (175 mg) as white crystals.  
 
7,7-Dimethyl-tetrahydro-3a,6a-methano- 
pentalene-1,4-dione (84): 
 
7
1
O
3
4
O
M
178 (100, M+, C11H14O2), 136 (8 1 (55), 93 (86), 91 
79 (38), 77 (25)
 
HRM (EI; m/z): 
calculated for C11H14O2: 178.099380; found: 178.099544. 
1H NMR 
2.65-2.55 (
(s, 6H, CH3). 
 
13C NMR  (100.6 MHz, 
213.17 (Cq, C-1, 4); 55.58 (Cq, C-8, 9); 43.09 (CH2, C-2, 5); 34.74 (Cq, C-7); 
19.22 (CH3, C
Mp            13-114 °C. 
(KBr):   
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3405w, 2932m, 1707s, 1456m, 1406m, 1374w, 1318m, 1289w, 1168m, 1098m, 
1042m, 1032m, 1002m. 
5.3.9 Tr
 
62 mg (0.91 mmol) of 84 were dissolved in acetic acid (5 ml) at room temperature and 
s stirred at room temperature for 15 
ours, then was washed with sat. sodium hydrogencarbonate solution and dried with 
 
  
214 (14, M+, C11H15O2
(15), 123 (30), 109(17), 95 (16), 93 (22), 81 (18), 79 (23), 77 (17), 67 (25), 55 
), 39 (19).  
 
HRMS      
76057; found: 214.076257.  
:  
, 6H); 1.69 (s, 3H, 
CH3); 1.60 (s, 3H, CH3).  
13C NMR 
Cq, CO); 73.17 (Cq; C-8); 65.50 (Cq, C-9); 54.33 (CH, 
C-7); 38.71 (CH2, C-3); 37.94 (CH2); 29.54 (CH3); 28.57 (CH3); 27.57 (CH2); 
 
eatment of 84 with HCl in HOAc (→ 89a) 
1
fuming HCl (0.5 ml, 37 %) were added. The mixture wa
h
anhydrous sodium sulfate. After evaporation of the solvent, the residue was chromatographed 
on silica gel using pentane-ether (1:1) as eluating solvent to give white crystalline 89a (159 
mg, 81.4 %) as the first fraction; the second fraction was 78 (page 66) (10 mg, 15 %) as a 
white crystalline material.  
 
 3a-(1-Chloro-1-methyl-ethyl)-hexahydro- 
pentalene-1,4-dione (89a):
8
7
24
O
1
O9
Cl
 
 
MS            (EI; m/z, rel. int.):
), 179 (27), 178 (92), 151 (15), 136 (100), 135 (34), 124 
(46), 53 (17), 41 (30
(EI; m/z):  
calculated for C11H15ClO2: 214.0
 
1H-NMR   (400 MHz)
3.15 (d, J=9.22, 1H, CH); 2.46-2.44 (m, 2H); 2.26-2.09 (m
 
(100.6 MHz, BB, DEPT, 1H; 13C-COSY):  
219.24 (Cq, CO); 218.87 (
23.32 (CH2). 
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Mp 
 
IR 
33s, 1455w, 1403w, 1391w, 1375w, 1277w, 1225w, 1200w, 
1147m, 1105w, 878w, 644w. 
5.3.10 Tr
 
201.5 mg (1.13 mmol) of 84 was dissolved in carbontetrachloride (10 ml) and 0.23 ml HBr 
erature for 17 hours and the mixture 
as washed with sodium hydrogencarbonate and dried with anhydrous sodium sulfate, after 
:  
258 (5, M+, C11H15BrO2), 179 (100), 151 (27), 123 (22), 55 (46). 
S 
  
, 6H); 1.91 (s, 3H, 
CH3); 1.82 (s, 3H, CH3).   
  BB, DEPT, 1H; 13C-COSY):  
(CH2); 31.37 (CH3); 30.34(CH3); 28.73 (CH2); 23.34 
Mp            108-110 °C.  
84.5-85.5 °C. 
(KBr):  
3447w, 2954w, 17
 
eatment of 84 with HBr in HOAc (→ 89b) 
(48 %) was added. The mixture was stirred at room temp
w
evaporation of solvent, the residue was chromatographed on silica gel using pentane-ether 
(1:1) as eluating solvent to give white crystal 89b (262 mg, 82.1 %) as the first fraction, the 
second fraction is 78 (page 66) (82.6 mg, 13 %) as white crystalline material. 
 
 3a-(1-Bromo-1-methyl-ethyl)-hexahydro- 
pentalene-1,4-dione (89b): 8
7
24
1
O9
Br
O 
 
MS (EI; m/z, rel. int.)
 
 
HRM (EI; m/z):  
 calculated for C11H15BrO2: 258.025555; found: 258.025501. 
 
1H NMR (400 MHz):
3.20 (d, J=9.19, 1H, CH); 2.52-2.47 (m, 2H); 2.32-2.07 (m
13C NMR  (100.6 MHz,
219.13 (Cq, CO); 218.04 (Cq, CO); 70.87 (Cq, C-8); 66.15 (Cq, C-9); 56.02 (CH, 
C-7); 39.01 (CH2); 37.95 
(CH2).  
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IR 
179w, 1132w, 1118w, 1102w, 1084w. 
11 De  90) 
 
(a) 273 mg  in 20 ml ethylacetate, 
01 mg 5% Pt-C was added in a two-necked flask which was connected to water pump and 
s evacuated at water pump pressure until evolution 
f bubbles then the valve of the hydrogen-filled balloon was opened. This process was 
as concentrated in 
acuo and the residue chromatographed on silica gel with pentane/ether (4:1) to give 90 (68 
S (EI; m/z, rel. int.):  
52 (16), 137 (1 18), 109 (45), 82 
5), 79 (14), 67 (19), 55 (21), 41 (24). 
S 
 
(KBr):   
3432m, 2899w, 1729s, 1477w, 1457w, 1412w, 1389w, 1371w, 1285wm 
1215w,1
 
5.3. halogenation of 89b (→
 (1.1 mmol) of 89b and 0.3 ml triethylamine were dissolved
1
hydrogen-filled balloon. This mixture wa
o
repeated for several times. Then the reaction was left to react under hydrogen and was 
monitored by TLC. After the catalyst was filtered, the organic phase was washed with diluted 
HCl (20%, v/v) and washed with brine, before drying over anhydrous sodium sulfate. The 
solvent was evaporated in vacuo and the residue was chromatographed on silica gel with 
ether/pentane (1:5). The first fraction contained 90 as colorless liquid (91 mg, 48%) and the 
second fraction consisted of 78 (73.6 mg, 37%) was the second fraction.  
 
(b) 89b (130 mg, 0.5 mmol) was dissolved in 10 ml dry benzene under argon atmosphere. 
After adding AIBN (6 mg) and Bu3SnH (0.27 ml, 1 mmol), the reaction mixture was refluxed 
for four hours and cooled to room temperature. The reaction mixture w
v
mg, 75 %).  
 
3a-Isopropyl-hexahydro-pentalene- 
1,4-dionedione (90): 
 71
O
3
4
O9
M
180 (40, M+, C11H16O2), 1 00), 125 (72), 110 (
(23), 81 (2
 
HRM (EI; m/z):  
calculated for C11H16O2: 180.115030; found: 180.115244. 
 71 
 
 
1H NMR (400 MHz):  
); 2.33-2.27 (m, 2H); 2.14-2.04 (m, 5H); 1.97-1.85 (m, 2H); 0.90 (d, 
 
BB, DEPT, 1H; 13C-COSY): 
 
(CH2); 22.50 (CH2); 18.18 (CH3); 
7.83 (CH2).  
 
 
.3.12 Reaction of 84 with borontrifluoride-etherate (→ 96) 
BF3·Et2O (F  to a solution of 147 mg (0.827 
mol) of diketone 84 in acetic anhydride (10 ml) under stirring and argon. The mixture was 
 were added. The reaction 
ixture was let to warm slowly to room temperature and was saturated with sodium chloride, 
S (EI; m/z, rel. int.): 
80 (37), 179 (14), 
RMS (EI; m/z):  
20O5: 280.131075; found: 280.131273. 
 
2.65 (m, 1H
J=6.91, 3H, CH3); 0.86 (d, J=6.81, 3H, CH3).  
13C NMR (100.6 MHz, 
222.13 (Cq, CO); 220.41 (Cq, CO); 61.06 (Cq, C-7); 52.65 (CH, C-8); 37.91 
(CH2); 37.70 (CH2); 32.97 (CH, C-9); 27.36 
1
 
IR (KBr):  
3421w, 2964w, 1734s, 1472w, 1408w, 1372w.  
5
 
luka, 0.32 ml, 2.5 mmol) was added at –78 °C
m
stirred for 6 hours at room temperature, then 15 ml of ice-water
m
then extracted with ether and the organic layer washed with saturated solution of sodium 
hydrogencarbonate. Before the evaporation of the solvent, the solution was dried over 
anhydrous sodium sulfate and the residue was chromatographed on silica gel with 
pentane/ether (1:5) to obtain 96 as a colorless oil (143 mg, 61.6%) and 78 (22 mg, 7%) as 
crystalline material.  
 
Acetic acid 3a-(1-acetoxy-1-methyl-ethyl)- 
4-oxo-2,3,3a,4,5,6-hexahydro-pentalen-1yl ester (96): 
 54
O
2
8 1
O9
13O
O
11
O
M
280 (1, M+, C15H20O5), 222 (11), 1 178 (22), 150 (13), 139 (12), 
138 (100), 137 (11), 43 (56).  
H
 calculated for C15H
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1H NMR 
 (m, 3H); 2.73-2.05 (m, 2H); 2.12 (s, 3H, CH3); 
, 2H); 1.89 (s, 3H, CH3); 1.59 (s, 3H, CH3); 1.58 (s, 3H, CH3).  
C NMR (100.6 MHz, BB, DEPT, 1H; 13C-COSY):  
-4); 168.96 (Cq, C-9); 167.63 (Cq, C-10); 146.81 (Cq, C-8); 129.62 
3).  
 
 
5.3.13 Reduction of 84 with sodium borhydride (→ 97)  
84 (350 mg
boronhydri l) at 0 °C. The reaction mixture was stirred at room 
mperature for 8 hours. After addition of 1 ml of water, the solvent was evaporated and the 
97 as white 
rystals (323 mg, 91.5%).  
S (EI; m/z, rel. int.):  
, 152 (15), 36 (19), 123 
26), 119 (32), 107 (100), 105 (63), 93 (43), 91 (41), 79 (36), 
77 (23), 67 (20), 55 (20), 43 (21), 41 (28), 39 (21).  
S 
calculated for C11H16O2: 180.115030; found: 180.115209. 
 
(400 MHz):  
2.95-2.80 (m, 1H); 2.52-2.46
1.99-1.91 (m
 
13
217.30 (Cq, C
(Cq, C-1); 88.07 (Cq, C-5); 67.65 (Cq, C-13); 41.65 (CH2); 33.85 (CH2); 28.62 
(CH2); 22.45 (CH3, C-10); 21.73 (CH2); 20.60 (CH3); 20.38 (CH3); 19.88 (CH
IR (KBr):  
3457w, 2944w, 1737s, 1446w, 1386w, 1369m, 1326w, 1251m, 1192s, 1129m, 
1052w, 1013w, 935w. 
 
, 1.96 mmol) was dissolved in 15 ml methanol followed by addition of sodium 
de (22 mg, 0.59 mmo
te
residue chromatographed on silica gel using pentane/ether (3:1) as eluant to give 
c
 
4-Hydroxy-7,7-dimethyl-tetrahydro-3a,6a- 
methano-pentalen-1-one (97): 
 
 
7
3
1
O
4HO
M
180 (34, M+, C11H16O2), 165 (17) 147 (17), 137 (21), 1
(90), 121 (21), 120 (
 
HRM (EI; m/z):  
 73 
 
 
1H NMR 
 B, DEPT, 1H; 13C-COSY): 
.31 (Cq, C-9); 44.12 
H2); 42.28 (CH2); 35.25 (Cq, C-7); 25.41 (CH2); 24.10 (CH2); 20.72 (CH3); 
 
Mp            
                
 
 
.3.14 Esterification of 97 (→ 98) 
ydroxyketone 97 (169 mg, 0.95 mmol) was dissolved in 5 ml pyridine at room temperature 
 heated °C for 2 hours. After distilling off the solvent, the residue was dissolved 
 10 ml 
vaporation ed. Chromatography of the residue on silica gel 
ave 98 as white crystals (174 mg, 83%).  
222 (5, M , C13H18O3), 180 (34), 179 (17), 162 (46), 136 (15), 134 (45), 121 (16), 
120 (69), 119 (100), 107 (34), 106 (17), 105 (86), 93 (20), 91 (38), 79 (20), 77 
(250 MHz): 4.75 (dd, J=5.62, 9.90, 1H, -CH-); 2.62-2.48 (m, 2H); 2.27-2.16 (m, 
2H); 2.10-1.95 (m, 2H); 1.87-1.81 (m, 2H); 1.60-1.50 (m, 1H); 1.41 (s, 3H, CH3); 
1.22 (s, 3H, CH3).  
 
13C NMR (63 MHz, B
216.47 (Cq, C-1); 82.0 (CH, C-4); 56.96 (Cq, C-8); 53
(C
20.63 (CH3).  
97-98  °C. 
 
IR (KBr):  
3354s (br.), 2944m, 1713s, 1448w, 1404w, 1327w, 1281w, 1099w, 1059m,   
1042m, 1025m, 1009w, 669w. 
5
 
H
and at 88-90 
in ethyl acetate and washed with brine. Next, drying over sodium sulfate and 
e  of the solvent in vacuo follow
g
 
 
Acetic acid 7,7-dimethyl-4-oxo-tetrahydro- 
3a,6a-methano-pentalen-1-yl ester (98): 
 
 
MS (EI; m/z, rel. int.):  
+
7
3
1
O
4O10
O
(17), 43 (63), 41 (20). 
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HRMS (EI; m/z):  
calculated for C13H18O3: 222.125595; found: 222.125440. 
1H NMR 
, 2H); 2.0 (s, 3H, CH3); 1.91-1.84 (m, 1H); 1.79-1.61 (m, 
1H);  1.33 (s, 3H, CH3); 1.23 (s, 3H, CH3).  
 
13C NMR 
15.24 (Cq, C-1); 171.06 Cq, C-10); 83.22 (CH, C-4); 56.59 (Cq, C-8); 53.94  
.22 (CH2); 38.79 (CH2); 34.77 (Cq, C-9); 25.14 (CH2); 23.31 (CH2); 
 
Mp 
 
 
 
.3.15 Treatment of 98 with HCl in HOAc (→ 102-105) 
t room temperature, 98 (410 mg, 1.85 mmol) was dissolved in 10 ml CCl4 under stirring, 
hydrochloric acid (37%) was added. This mixture was stirred for further 
12 hoursat 
solution. T  on silica gel with pentane/ether 
:1) to give the following 4 products:  
 
(400 MHz): 
5.36 (dd, J=5.03, 10.21, 1H); 2.75-2.60 (m, 1H); 2.59-2.53 (m, 1H); 2.28-2.20 
(m,  2H); 2.15-2.07 (m
(100.6 MHz, BB, DEPT, 1H; 13C-COSY): 
2
(Cq, C-9); 43
20.99 (CH3, C-11); 20.03 (CH3); 19.73 (CH3).  
82-83 °C. 
IR             (KBr):  
3450m (br), 2950m, 2918m, 1736s, 1707s, 1457w, 1407w, 1377m, 1351w, 
1325m, 1280m, 1251s, 1098m, 1050m, 1023s. 
5
 
A
then 0.2 ml fuming 
room temperature before washing it with saturated sodium hydrogencarbonate 
he concentrated residue was chromatographed
(5
 
 
Product 102: 127 mg (26.6%), pale yellow oil.  
                                                                                                   
Acetic acid 6a-(1-chloro-1-methyl-ethyl)- 
4-oxo-octahydro-pentalen-1-yl ester (102): 
 
8
4
7
24
1
O9
10Cl
12
O
O
 75 
 
 
MS    (EI; m/z, rel. int.):  
258 (7, M+, C13H19ClO3), 222 (13), 198 (15), 181 (19), 180 (100), 163 (21), 152 
21 (20), 107 (17), 93 (18), 79 (19), 43 (67), 
calculated for C13H19ClO3: 258.102273; found: 258.102449. 
1H NMR    
2.25-2.05 (m, 1H); 2.04 (s, 3H, CH3); 1.90-1.80 (m, 2H); 1.79 (s, 3H, 
CH3); 1.69 (s, 3H, CH3).  
13C NMR 
221.13 (Cq, C-1); 169.68 (Cq, C-12); 82.95 (CH, C-4); 62.98 (Cq, C-9); 54.33 
.09 (CH, C-7); 37.80 (CH2); 32.21 (CH2); 30.96 (CH2); 29.38(CH3); 
 
IR              
3448w, 2978w, 1737s, 1637w, 1458w, 1391w, 1374w, 1239s, 1144w, 1039w. 
 
Product 103
 
imethyl-1-oxo-2,3,4,5,6,7- 
hexahyd
S (EI; m/z, rel. int.):  
+ 162 (100), 152 (85), 147 (63), 137 (46), 136 
(89), 135 (22), 121 (23), 120 (42), 119 (50), 105 (61), 93 (26), 91 (25), 79 (19), 
77 (19), 43 (78), 41 (17).  
 
(56), 137 (29), 136 (55), 123 (18), 1
41 (16).  
 
HRMS     (EI; m/z): 
 
(500 MHz):  
5.12-5.10 (m, 1H, CH3); 2.91-2.88 (m, 1H, CH); 2.56-2.50 (m, 3H); 2.35-2.33 
(m, 2H); 
 
(125.8 MHz, BB, DEPT, 1H; 13C-COSY):  
(Cq, C-8); 41
28.46 (CH3); 27.82 (CH2); 21.46 (CH3). 
(KBr):  
 
:  59 mg (14.4%), pale yellow oil.  
7
5
O
9
1
O
10
O
 
Acetic acid 4,4-d
ro-1H-inden-5-yl ester (103): 
 
M
222 (48, M , C13H18O3), 180 (84), 
 76 
 
 
HR
calculated for C13H18O3: 222.125646; found: 222.125595. 
1H NMR 
, 3H, CH3); 1.86-1.84 (m, 2H, CH3); 1.15 (s, 3H, CH3); 
1.13 (s, 3H, CH3).   
13C NMR 
208.67 (Cq, C-1); 176.67 (Cq, C-10); 170.57 (Cq, C-9); 136.52 (Cq, C-8); 76.55 
.40 (Cq, C-4); 34.54 (CH2); 25.45 (CH3, C-11); 24.87 (CH2); 22.97 
 
IR              
457w, 2968w, 1736s, 1700s, 1641m, 1374w, 1244s, 1046w, 1033w. 
 
Product 104
 
-Hydroxy-4,4-dimethyl-2,3,4,5,6,7- 
-one (104): 
 
S             (EI; m/z, rel. int.):  
180 (100, M+, C11H16O2), 152 (48), 137 (48), 136 (88), 135 (37), 123 (10), 121 
), 55 (10), 43 (15), 41 (14), 39 (11). 
O2: 180.115030; found: 180.115261. 
(400 MHz):  
2.48 (m, 2H); 2.38-2.36 (m, 2H); 2.24-2.05 (m, 2H); 1.95-
C NMR (100.6 MHz, BB, DEPT, 1H; 13C-COSY):  
MS (EI; m/z):  
 
(400 MHz):  
4.89-4.91 (m, 1H, CH); 2.50-2.51 (m, 2H, CH2); 2.40-2.37 (m, 2H, CH2); 2.20-
2.17 (m, 2H, CH2); 2.04 (s
 
(100.6 MHz, BB, DEPT, 1H; 13C-COSY):  
(CH, C-5); 38
(CH2); 21.60 (CH3); 21.07 (CH3); 17.30 (CH2). 
(KBr):  
3
 
: 47.5 mg (14.3%), pale yellow oil.  
7 1
O
5
hexahydro-inden-1
5
HO
9
M
(40), 93 (44), 91 (18), 79 (21), 77 (17
 
HRMS (EI; m/z):  
calculated for C11H16
1H NMR 
3.67 (m, 1H); 2.51-
1.85 (m, 2H); 1.64 (s, 1H, HOC-3); 1.17 (s, 3H, CH3); 1.14 (s, 3H, CH3).  
 
13
 77 
 
 
209.00 (Cq, C-1); 178.02 (Cq, C-9); 136.26 (Cq, C-8); 75.16 (CH, C-5); 39.58 
 (CH2); 20.74 (CH3); 
 
IR              
431s, 2965m, 2934m, 2870m, 1673s, 1628s, 1437w, 1389w, 1231w, 1175s, 
 
Product 105 .2%), pale yellow oil.  
hyl-ethyl)-3,5,6,6a- 
tetrahydro
 
 
S (EI; m/z, rel. int.):  
156 (21), 121 (100), 119 (61), 107 (29), 91 
(34).  
calculated for C11H15ClO: 198.081143; found: 198.081080. 
MR   
.06 (m; 1H); 1.94-1.89 (m, 1H); 1.71 (s, 3H, CH3); 1.60 (s, 3H, CH3).  
 
C NMR (125.8 MHz, BB, DEPT):  
C ); 148.53 (Cq, C-8); 129.50 (CH, C-4); 73.01 (Cq,  C-9); 70.95 
 
(Cq, C-4); 34.70 (CH2); 26.20 (CH2); 25.17 (CH3); 25.04
17.67 (CH2). 
(KBr):  
3
1051m. 
 
: 37.5 mg (10
 
6a-(1-Chloro-1-met
8
6
4
1
Cl
-2Hpentalen-1-one (105): O
M
198 (54, M+, C11H15ClO), 163 (14), 
 
HRMS (EI; m/z):  
 
1H N  (500 MHz):  
5.85 (dd, J=1.58, 1.36); 2.91-2.67 (m, 1H); 2.56-2.52 (m, 2H); 2.44-2.34 (m, 2H); 
2.10-2
 
 
13
217.24 (Cq, -1
(Cq, C-7); 42.47 (CH2); 34.75 CH2); 33.42 (CH2); 29.43 (CH3); 28.62 (CH3); 
24.99 (CH2).  
 78 
 
 
IR Br):  
445w, 2987w, 2939m, 1735s, 1658w, 1459w, 1443w, 1393w, 1387w, 1371m, 
 
5.3.16 Ox
 
iketone 84 (179 mg, 1 mmol) was dissolved in 20 ml benzene, then 700 mg (1.5 mmol) 
 tetraac %, Acros) and 5 ml acetic acid were added and the mixture was stirred at 
room tempe
and the aqueous phase was extracted with ether. The combined organic layers were washed 
ith saturated sodium hydrogencarbonate solution and brine. Before evaporating the solvent, 
organic layer 
oncentrated. The residue was chromatographed on silica gel with pentane/ether (1:3) to give 
S             (EI; m/z, rel. int.):  
236 (0.3, M+, C13H16O4), 194 (35), 179 (50), 176 (100), 166 (58), 137 (25), 134 
(33),  43 (78), 41 
RMS (EI; m/z):  
calculated for C13H16O4: 236.104860; found: 236.104930. 
(K
3
1208m, 1102w, 805m. 
idation of diketone 84 with lead tetraacetate (→ 115 and 116) 
D
lead etate (95
rature for 6 days. After adding 15 ml of water, the organic phase was separated 
w
the organic phase was dried over anhydrous sodium sulfate and the 
c
115 (123 mg, 53%) and 116 (47 mg, 16%) as whit crystalline materials.   
 
 
Acetic acid 7,7-dimethyl-1,4-dioxo-tetrahydro- 
3a,6a-methano-pentalen-2-yl ester (115): 
  
 
 
7
3
1
O
4
O
O
10
O
M
(69), 133 (22), 123 (60), 105 (31), 91  79 (26), 77 (22), 55 (18),
(19).  
 
H
1H NMR (400 MHz):  
4.51 (dd, J=4.99, 8.46, 1H); 2.75-2.69 (m, 1H); 2.58-2.17 (m, 5H); 2.03 (s, 3H, 
CH3); 1.29 (s, 3H, CH3); 1.23 (s, 3H, CH3).  
 
 
 79 
 
 
13C NMR (100.6 MHz , BB, DEPT, 1H; 13C-COSY):  
1.37 (CH, C-2); 54.16 
.55 (Cq, C-9); 42.30 (CH2); 35.65 (Cq, C-7); 27.99 (CH2); 20.60 
 
Mp 10-111 °C. 
 
 
cetic acid 5-acetoxy-7,7-dimethyl-1,4-dioxo- 
no-pentalen-2-yl 
ster (116): 
MS 
294 (4, M+, C15H18O6), 252 (13), 224 (27), 195 (15), 177 (19), 174 (38), 164 (33), 
149 (32), 136 (31), 135 (19), 121 (22), 93 (10), 91 (10), 43 (100).  
lculated for C15H18O6
1H NMR 00 MHz): 4.84 (dd, J=4.55, 8.50, 2H); 2.58 (dd, J=8.45, 14.80, 2H); 2.30 (dd, 
 2.0 (s, 6H, CH3); 1.32 (s, 6H, CH3).  
 
13C NMR 
206.14 (Cq, C-1,4); 170.09 (Cq, C-12, 14); 79.17 (CH, C-2,5); 51.74 (Cq, C-8, 
q, C-7); 28.04 (CH2, C-4, 6); 20.88 (CH3); 20.43 (CH3). 
 
R (KBr):  
 1231s, 1167w, 1067w, 1022m. 
 
212.86 (Cq, C-1); 207.70 (Cq, C-4); 170.26 (Cq, C-10); 8
(Cq, C-8); 53
(CH3); 20.33 (CH3); 19.70 (CH2); 19.44 (CH3).  
1
 
IR (KBr):  
3442w (br.), 2957w, 1726s, 1383w, 1314w, 1229m, 1195w, 1071w, 1027w.  
7
3
1
O
4
O
O
10
O
O12
OA
tetrahydro-3a,6a-metha
 e
  
(EI; m/z, rel. int.):  
 
HRMS (EI; m/z):  
 ca : 294.110340; found: 294.110090. 
(4
J=4.54, 14.83, 2H); 7 
(100.6 MHz, BB, DEPT, 1H; 13C-COSY):  
9); 36.29 (C
 
Mp 162-163 °C. 
I
3456w (br.), 2953w, 1730s, 1448w, 1377w,
 80 
 
 
5.3.17 Bi
 
Liquid ammonia (50 ml) was distilled into a three-necked flask, cooled to –78 °C, followed 
.21 mmol) lithium which resulted in the formation of a deep blue 
olution. To this solution was added a solution of diketone 84 (92 mg, 0.52 mmol) in 5 ml 
THF, t action was stirred for further 2 hours. After adding 1 g of sodium 
chloride, th rated 
and 15 ml water were added. The mixture was extracted with ethyl acetate and the organic 
ate. After evaporation of the solvent at reduced 
ressure, the residue was chromatographed on silica gel with pentane/ether (1:3) to give 123 
om temperature, 4 ml ethanol was added to 
estroy the excess sodium. Next, 20 ml saturated NH4Cl solution was added, the organic 
xtracted with ether. 
he combined organic layers were dried over anhydrous sodium sulfate and concentrated in 
ith sodium was observed; a total of 4.6 mg (198.98 
mol) sodium was consumed. Then, the organic phase was separated and the aqueous phase 
rch Reduction of 84 (→ 123) 
by addition of 57 mg (8
s
dry hen the re
e solution was slowly warmed to room temperature. Ammonia was evapo
layers dried over anhydrous sodium sulf
p
(58 mg, 60.2%) as white a crystalline product.  
 
5.3.18 Reduction of 84 with sodium in toluene-isopropanol (→ 123) 
 
Sodium was heated in 7.5 ml toluene to reflux under vigorous stirring and argon to give 
finely dispersed sodium, then a solution of diketone 84 (92 mg, 0.516 mmol) in 253 ml 
isopropanol was added, the solution kept under reflux and 3.5 hours later additional 99 mg of 
sodium and 311 mg isopropanol were added and the stirring was continued for further 2 
hours. After cooling the reaction mixture to ro
d
phase was separated after extraction and the water phase was separately e
T
vacuo. Chromatography of the residue on silica gel with pentane/ether (1:3) afforded 123 (64 
mg, 68%) as a white crystalline product.  
 
5.3.19 Reduction of 84 with sodium in ether saturated by NaHCO3 (→ 123) 
 
To a solution of diketone 84 (89 mg, 0.5 mmol) in 10 ml diethylether was added 1 ml of 
saturated sodium bicarbonate solution and sodium was carefully added in a small pieces at 0 
ºC under stirring. After the initial sodium disappeared sodium, further small pieces of sodium 
were added until the reaction was completed (monitored by TLC). Thereafter water was 
added ml by ml until no further reaction w
m
 81 
 
 
was extracted repeatedly with ether and dried over sodium sulfate. After concentration, the 
sidue was purified by chromatography on silica gel using pentane/ether (1:3) as eluent to 
49 (44), 122 (23), 121 (28), 111 
(83), 109 (37), 107 (47), 106 (21), 99 (22), 98 (20), 96 (96), 93 (28), 84 (21), 83 
(74), 79 (28), 70 (20), 69 (100), 67 (24), 55 (55), 43 (54), 41 (64).  
calculated for C11H18O2: 182.130680; found: 182.130416. 
13C NMR 
84.90 (Cq, C-1, 4); 49.71 (CH, C-8,9); 31.62 (Cq, C-7); 26.70 (CH2); 24.99     
6 (CH2).  
 
p 149-150 °C. 
IR 
417s (br.), 2955m, 1636w, 1384m, 1128m, 1062w. 
 
re
give 123 (76.1 mg, 83.5%) as a white crystalline product.  
 
 
7,7-Dimethyl-tetrahydro-1,4-methano- 
pentalene-3a,6a-diol (123): 
  
 
MS             (EI; m/z, rel. int.):  
182 (98, M+, C11H18O2), 167 (44), 164 (47), 1
8
3
1
OH
4
HO
7
 
HRMS       (EI; m/z):  
 
1H NMR    (250 MHz):  
1.91-1.87 (m, 2H); 1.58-1.51 (m, 6H); 1.36-1.31 (m, 2H); 0.92 (s, 6H, CH3).  
 
(63 MHz, BB, DEPT, 1H; 13C-COSY):  
(CH3); 21.7
M
 
(KBr):  
3
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5.3.20 Oxidation of pinacol 123 with lead tetraacetate (→ 85) 
To a suspe te benzene was added lead 
tetraacetate (95%, Fluka, 131 mg, 0.28 mmol) with stirring at room temperature  and under 
argon. After stirring for 6.5 hours, 0.3 ml glycerine was added and the mixture was warmed 
to 45 °C to destroy the excess of lead tetraacetate.  The mixture was filtered by washing the 
residue with toluene. The combined organic layers were dried over anhydrous sodium 
sulphate prior to evaporation of the solvents. Chromatography of the residual crude product 
yield (20.6 mg).  
RMS (EI; m/z):  
d: 180
(400 MHz):  
Hz, J=18.1Hz); 2.38-2.28 (m, 2H); 2.18-2.12 (m, 1H); 1.88 
 
C NMR (100.6 MHz, BB, DEPT, 1H; 13C-COSY):  
, C-2,6); 54.72 (C-1,5); 37.25 (Cq, C-9); 36.04 (CH2, C-3,7);  26.25 
 
IR 
3440w (br), 2965w, 2910m, 1692s, 1458w, 1435w, 1326w, 1235w, 1031w, 
 
nsion of 123 (36 mg, 0.2 mmol) in 10 ml absolu
on silica gel with pentane/ether (1:4) gave the desired 85 with 57% 
  
9,9-Dimethyl-bicyclo[3.3.1]nonane-2,6-dione (85): 
 
 
MS (EI; m/z, rel. int.):  
180 (27, M+, C11H16O2), 137 (11), 112 (92), 95 (10), 82 (14), 81 (15), 69 (100), 
67 (19), 55 (19), 41 (30).  
 
1
4
2
O
6
O
9
H
calculated for C11H16O2: 180.115030; foun .115276. 
 
1H NMR 
2.56 (dd, 1H, J=7.9
(dd, 1H, J=9.5Hz, J=14.5Hz); 0.97 (s, 6H, CH3).  
13
212.89 (Cq
(CH3, C-10,11); 22.57 (CH2, C-4,8).  
 
Mp 140-141 °C. 
(KBr):  
744w.   
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5.3.21 Sy
 
raphite (970 mg, 70.76 mmol) was placed in a two-necked flask and heated under argon 
sphere to degas for 20 min at 160 °C before freshly cut potassium (390 mg, 9.98 mmol) 
as added under vigorous stirring. Bronze-colored laminate of graphite and potassium (C8K) 
 formed. After cooling to room temperature, 20 ml dry THF was added by syringe. To 
this suspen
temperature rred for 5 days at the same temperature. After adding 5 ml MeOH, 
hase was 
oncentrated in vacuo and chromatographed on the silica gel with pentane-ether (5:1) to give 
 mixture of 9,9-dimethyl-bicyclo[3.3.1]nonane-2,6-dione (85) (0.678 g, 3.76 mmol), 1,2-
thanediol (130) (0.233 g, 3.76 mmol) and p-TsOH m
uxed for 4.5 hours in a Dean-Stark 
ooling, reaction mixture was washed with saturated aq. NaHCO3 (60 ml) 
nd NaCl (2 x 50 ml). After drying over anhydrous Na2SO4, the solvent was evaporated in 
acuo and the residue chromatographed on silica gel with pentane/ether (1:2) as eluent to 
 g, 63 % yield) as a crystalline material.  
  224 (10.2, M+, C13H20O3), 100 (99), 86 (54.5), 55 (16.2).  
nthesis of 9,9-Dimethyl-bicyclo[3.3.1]nonane-2,6-dione (85) from 84 
G
atmo
w
was
sion was added solution of 84 (358 mg, 2.0 mmol) in 20 ml of dry THF at room 
 and sti
graphite was filtered off and washed extensively with ethyl acetate, the organic p
c
white crystalline 85 (1.18 mmol,  212 mg, 59%).  
  
 
9,9-Dimethyl-bicyclo[3.3.1]nonane-2,6-dione (85),  
(data see p. 83): 
 
 
5.3.22 Synthesis of 131 
 
O
O
A
e onohydrate (0.071 g, 0.37 mmol) in 
200 ml of toluene was vigorously stirred and refl
apparatus. After c
a
v
give the product 131 (53 m
 
5
8
1
9
3
11
O
O
12 O
131
 
Monoketal 131:  
 
 
MS   (EI; m/z, rel. int.):  
 84 
 
 
HRMS   (EI; m/z): 
calculated for C13H20O3: 224.141245; found: 224.141486. 
(400 MHz, 1H-1H-COSY, CDCl3):  
78 (m, 4H); 2.39 (dd, 1H, J=9. z, J=19.2Hz); 2.25 (dd, 1H, J=9.7Hz, 
J=19.2Hz); 2.17-2.11 (m, 1H); 2.04-1.85(m 3), 0.91 (s, CH3).  
 
MR T, 1H-13C-COSY, CDCl3): 
.30 (CH2, C-13); 55.70 
 44.72 (CH, C-5); 36.43 (CH2); 35.66 (Cq, C-9); 30.66 (CH2); 29.22 
 
 
 
Mp 53 °C. 
5.3.23 Sy
 
To a soluti 0.272 mmol) in CH2Cl2 (8 ml), 
TBDMSOTf (0.057 ml, 86.2 mg, 0.323 mmol), followed by NEt3 (0.094 ml, 0.69 mg, 0.68 
ise at room temperature. After stirring for 10 min at room 
mperature ith CH2Cl2 (3x 20 
l). The combined organic layers were dried with NaSO4. After filtration, the solvents were 
ced pressure at 25 °C. The crude product was purified by 
hromatography on a silica gel column with pentane as eluent to give the silylated enol ether 
uantitative yield).   
 
1H NMR 
3.97-3. 2H
, 3H); 1.16 (s, CH
13C N (100 MHz, BB, DEP
215.95 (Cq, C-1); 110.87 (Cq, C-6); 64.64 (CH2, C-12); 63
(CH, C-1);
(CH3); 26.74 (CH3); 22.44 (CH2); 20.59 (CH2).  
IR (KBr): 
3454 (br.), 3011m, 2960s, 2974s, 1693s, 1455m, 1102s, 909m. 
 
nthesis of 132 
on of the monoprotected diketone 131 (61 mg, 
mmol), were added dropw
te , the mixture was hydrolyzed with water (5 ml) and extracted w
m
removed under redu
c
132 (0.09 g, 0.272 mmol, q
 
 
Siliylenol ether 132: 
 
  
 
8
1
9
6
4
2O
O
OSi
13
12
14
132
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MS  (EI; m/z, rel. int.):  
338 (54.0, M+, C19H34O3Si1), 294 (20.1), 293 (85.9), 99 (100.0), 75 (21.8), 73 
(47.0), 55 (17.0). 
 
HRMS ESIpos : m/z calcd for C19H34NaO
 361.217066, found: 361.217493.   
Hz, 1H-1H-COSY, CDCl3):  
4.69 (dd, 1H, J=2.7, 4.6Hz); 3.99-3.81 (m, 4H, CH2); 2.24 (dd, 1H, J=4.6Hz, 
d, 1H, J=2.7Hz, J=6.3Hz, J=18.0Hz); 1.87 (t, 1H, J=13.1Hz); 
CH3); 0.99 (s, CH3); 0.89 (s, 9H); 0.12 (s, CH3); 0.10 (s; CH3).  
 
-3 5 (CH2); 63.00 
(CH2); 45.56 (CH); 44.44 (CH); 34.52 (Cq); 28.16 (CH3); 28.13 (CH2); 26.91 
.43 (CH2); 22.21 (CH2); 17.95 (Cq, C-14); -
IR 
 
p 44 °C. 
5.3.24 At
 
ZrCl4 (0.11
methyl but-2-ynoate ( g, 0.51 mmol) was added. The resulting mixture 
was cooled to -78 °C, whereupon a solution of enol ether 132 (83 mg, 0.24 mmol) in CH2Cl2 
l) was 8 °C and for 10 min at room 
mperature, the mixture was hydrolyzed by the addition of saturated aqueous NaHCO3 
ter extraction with Et2O (3 x 30 ml), the combined organic layers were 
ried with NaSO4 and the solvents were removed at reduced pressure. The crude product was 
3Si1 (M+Na):  
calculated:
 
1H NMR (400 M
J=17.9Hz); 2.11 (dd
1.75 (dt, 1H, J=5.4Hz, J=13.3Hz); 1.62 (s, 1H); 1.56-1.45 (m, 2H); 1.35 (d, 1H, 
J=5.4Hz); 1.14 (s, 
  
13C NMR (100 MHz, BB, DEPT, 1H-13C-COSY, CDCl3):  
150.56 (Cq, C-2); 112.36 (Cq, C-6); 100.92 (CH, C ); 64.4
(CH3); 25.73 (CH3, C-15,16,17), 24
4.10 (CH3), -4.49 (CH3).  
 
3399 (br.) 2910s, 1706s, 1459m, 1435m, 1325m. 
M
 
tempted ZrCl4-catalyzed [2+2] reaction of 132 and methyl but-2-ynoate (133) 
 mg, 0.49 mmol) was suspended in CH2Cl2 (10 ml) and Et2O (1 ml) and then 
133)  (0.051 ml, 50.5 m
(1 m  added dropwise. After stirring for 10 min at -7
te
solution (5 ml). Af
d
 86 
 
 
 87 
 
 
hromatographed on silica gel with pentane:ether (10:1). Instead of the expected [2+2] 
s of 135  
iketone 85 (0.203 g, 1.13 mmol), 2,2-dimethylpropane-1,3-diol (134) (0.12 g, 1.13 mmol), 
nd p-TsOH (0.023 g, 0.01 mmol) were dissolved in toluene ixture 
 head. It was then cooled to 0 °C, diluted with 
t2O (10 mL), and then 10% aq. NaOH solution (3 mL) was added. After extraction with 
t2O (2 x 50 mL), the organic layers were collected, washed with saturated aqueous NaCl 
olution (100 ml), and dried with Na2SO4. Volatile components were then removed at 
 material was purified by chromatography on a silica gel column 
ith pentane: ether (10:1) as eluent and 0.27 g 135 was obtained (62% yield).    
3), 55 (21.9), 
41 (23.7). 
c
product, 85 and 131 were recovered with 45 and 41% yield, respectively.  
 
 
9,9-Dimethyl-bicyclo[3.3.1]nonane-2,6-dione (85),  
(data see p. 83): 
 
 
 
Monoketal 131, (data see p. 84): 
 
 
 
5.3.25 Synthesi
 
D
a  (50 ml). The resulting m
was refluxed for 17 hours with a Dean-Stark
E
E
s
reduced pressure. The crude
w
 
 Monoketal 135: 
  
 
 
 
MS  (EI; m/z, rel. int.):  
226 (10.7, M+, C16H26O3), 142 (12.6), 141 (100), 128 (36.5), 69 (35.
 
5
8
1
9
3
11
O
O
O
135
5 3
O
O
12 O
131
8
1
9
11
1
4
2
O
6
O
9
85
H SRM  (EI; m/z): 
calculated for C16H26O3: 266.188195; found: 226.187915. 
(400 MHz, 1H-1H-COSY, CDCl3): 3.57 (d, 2H, J=11.4Hz); 3.50 (d, 2H, 
, 1H, J=7.9Hz, J=17.8Hz); 2.36 (dd, 1H, J=9.0Hz, J=20.4Hz); 
 
  BB, DEPT, 1H-13C-COSY, CDCl3): 212.85 (Cq, C-2); 99.86 (Cq, C-
-1); 54.64 (CH, C-5); 
36.51 (CH2); 31.90 (CH2); 36, 40 (Cq); 30.25 (Cq); 29.83 (CH3); 26.04 (CH2); 
 
IR 
 r.), 2912s, 2854m, 1704m, 1459m, 1261m, 1031m.  
 
5.3.26 Sy
 
o a solution of the monoketal 135  (0.224 g, 0.84 mmol) in CH2Cl2 (40 ml), TBDMSOTf 
ol) followed by NEt3 (0.292 ml, 0.21 g, 2.11 mmol) were added 
ture, the mixture was 
ydrolyzed with water (10 ml) and extracted with CH2Cl2 (3 x 25 ml). The combined organic 
After filtration, the solvents were removed at reduced 
ressure and the crude product was purified by chromatography on a silica gel column with 
: ent to give the silylated enol ether 136 (0.2355 g,  quantitative 
ield). 
 
 
1H NMR 
J=11.3Hz); 2.52 (dd
2.24-1.95 (m, 5H); 1.50-1.37 (m, 1H); 1.14 (s, 6H, CH3); 1.1 (s, CH3), 0.78 (s, 
CH3). 
 
13C NMR (100 MHz,
6); 69.76 (CH2, C-12); 69.56 (CH2, C-13); 56.22 (CH, C
23.09 (CH3); 22.34 (CH2). 
(KBr): 
3416 (b
 
Mp 47 °C.  
nthesis of 136 
T
(0.194 ml, 0.223 g, 0.84 mm
dropwise at room temperature. After stirring for 10 min at room tempera
h
layers were dried with Na2SO4. 
p
pentane ether (10:1) as elu
y
 
Silylenol ether 136:  
 
8
1
9
6
2O
O Si
13
12
14
4O
136
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MS (EI; m/z, rel. int.): 
380 (57.2, M+, C22H40O3Si), 295 (10.7), 294 (32.3), 293 (100), 141 (87.7), 75 
(15.9), 73 (34.2), 69 (17.8), 55 (20.9).  
 
, 1H-1H-COSY, CDCl3
3.49 (d, 2H, J=11.1Hz); 2.14-2.07 (m, 3H); 3); 
1.13 (s, CH3), 1.06 (s, CH3); 0.9 (s, 9H, CH 3).  
MR T, 1H-13C-COSY, CDCl3): 150.52 (Cq, C-2); 101.12 (Cq, C-
 (Cq); 28.95 (CH3); 26.08 (CH3); 25.69 
(3C; CH3); 23.31 (CH3); 23.16 (CH2); 22.38 (CH3); -4.087 (CH3); -4.57 (CH3).  
IR 
 
 
ZrCl4·THF 
then methy g 
ixture was cooled to -78 °C, whereupon a solution of enol ether 136 (100 mg, 0.27 mmol) 
 dropwise. After stirring for 10 min at -78 °C and for 10 min at 
om tempe  NaHCO3 
olution (5 ml). After extraction with Et2O (3 x 30 ml), the combined organic layers were 
hromatographed on silica gel with pentane:ether (10:1) as eluent. Instead of the expected 
 
1H NMR (250 MHz ): 4.68 (t, 1H, J=3.5Hz); 3.60 (d, 2H, J=11.4Hz); 
 1.96-1.42 (m, 5H); 1.23 (s, 6H, CH
3); 0.11 (s, CH3), 0.99 (s, CH
 
13C N (63 MHz, BB, DEP
6); 100.80 (CH, C-3); 69.57 (CH2); 69.34 (CH2); 45.99 (CH); 35.80 (CH); 34.18 
(Cq); 30.03 (CH2); 29.66 (CH2); 29.62
 
(KBr): 
2927s, 2856m, 1666m, 1483m, 1361m, 1206m, 1146m, 1104s, 837m.  
 
5.3.27 Attempted ZrCl4-catalyzed [2+2] reaction of 136 and methyl but-2-ynoate (133) 
(143 mg, 0.378 mmol) was suspended in CH2Cl2 (10 ml) and Et2O (1 ml) and 
l but-2-ynoate (133)  (0.044 ml, 43 mg, 0.43 mmol) was added. The resultin
m
in CH2Cl2 (1 ml) was added
ro rature, the mixture was hydrolyzed by the addition of saturated aqueous
s
dried with NaSO4 and the solvents were removed at reduced pressure. The crude product was 
c
[2+2] product, 85 and 135 were recovered with 43 and 42 % yield, respectively. 
 
 
9,9-Dimethyl-bicyclo[3.3.1]nonane-2,6-dione (85),  
(data see p. 83): 
 
 
1
4
2
O
6
O
9
85
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 Monoketal 135 (data see p. 87):  
5
8
1
9
3
O
O
135
11
 
 
O
 
 
 
5.4 Quantum mechanical calculations  
ized m ented. Geometry optimizations 
ere performed for both structures, 138 and 145, employing density functional theory and 
e TURBOMOLE program package. The structures were plotted employing GOPENMOL. 
P is a fast density functional that has proven to give accurate geometrical parameters in 
any application studies. For the geometry optimization of 138 and 145, the SV(P) basis sets 
ere used. Complete geometry optimization, i.e. no geometrical parameters were fixed. One 
nab s were performed in vacuum. This is 
xpected to be a good approximation since aprotic solvent THF will be used in the 
 
Cartesian coordinates of the optim olecules are repres
w
th
B
m
w
reaso le conformer was studied. All calculation
e
experiment. Furthermore, only charge neutral systems were investigated. 
 
5.4.1 Data for the compound 138 
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Cartesian coordinates of structure 138 (Ångstroms) 
 
Atom              x              y               z 
 
C -0.5355  1.0939 -0.9823 
 
C -0.8031 -0.6934 -2.5893 
 
C -2.3037 -0.8878 -2.4758 
 
H -2.8337 -0.5846 -3.4075 
 
C -0.3833  0.7766 -2.5239 
 
C  0.0022 -1.7534 -2.3600 
 
 -2.5205 -1.9643 -2.3196 
3 
H -0.7934  2.1675 -0.8710 
 
H
 
C -2.8467 -0.0507 -1.279
 
H -3.6222 -0.6299 -0.7375 
 
C -1.7409  0.3329 -0.2683 
 
H -0.4990 -2.7317 -2.2377 
 
C  1.4876 -1.7862 -2.1031 
 
H  2.0448 -1.1971 -2.8670 
 
H  1.8345 -2.8309 -2.2491 
 
C  2.0020 -1.3350 -0.7311 
 
C  1.7028 -0.1981 -0.0220 
C  0.7905 .9997 -0.2037 
 
 2
 0
O  1.1579 .0203  0.3888 
 
 1.6909 C -1.3122 -3.3735 
 
 1.6341 H -2.3859 -3.1124 
 
 2.7524 H -1.0046 -3.2507 
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H -1.2124  1.4342 -4.4518 
 
C  1.0373  1.1320 -3.0334 
 
H  1.8671  0.7100 -2.4366 
 
H  1.1607  0.8046 -4.0891 
 
 2H  1.1703 .2355 -3.0041 
C  3.0744 .2800 -0.2224 
H  3.5066 .9993  0.7573 
H  2.6471 .3049 -0.1260 
H  3.9071 .3551 -0.9606 
C  2.5516 .0956  1.2128 
O  2.2122 .0998  2.3661 
O  3.7614 .5973  0.8639 
C  4.5994 .9959  1.9596 
H  4.1026 .7900  2.5568 
  4.8210  0.1343  2.6263 
H  5.5308 .3817  1.5009 
O -2.2181 .2713  0.6916 
O -1.3692 .8861  0.3740 
C -3.0515 .6957  1.7001 
H -3.9388 .2014  1.2372 
H -3.4223 .5574  2.2940 
C -2.2666 .3147  2.5939 
C -1.0314 .7366  1.7583 
H -0.6491 .7279  2.0780 
 
-2
 
-1
 
-3
 
-2
 
 0
 
-0
 
 0
 
 0
 
 1
 
H
 
 1
 
 1
 
-0
 
 0
 
 0
 
 1
 
-0
 
-0
 
-1
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H -0.2047 -0.0072  1.8980 
 
C -1.7855  0.3573  3.8940 
 
H -2.6452  0.6192  4.5520 
 
H -1.1110 -0.3158  4.4698 
 
H -1.2200  1.2898  3.6730 
 
C -3.1570 -1.5320  2.9050 
 
H -3.4024 -2.0899  1.9735 
 
H -2.6451 -2.2347  3.6007 
 
H -4.1149 -1.2236  3.3832 
 
H -3.3238  0.8914 -1.6179 
 
 
 
5.4.2 Data for the compound 145 
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Cartesian coordinates of structure 145 (Ångstroms) 
 
Atom              x                   y               z 
 
C -0.5355  1.0939 -0.9823 
 
C -0.8031 -0.6934 -2.5893 
 
C -2.3037 -0.8878 -2.4758 
 
H -2.8337 -0.5846 -3.4075 
 
C -0.3833  0.7766 -2.5239 
 
C  0.0022 -1.7534 -2.3600 
 
H -0.7934  2.1675 -0.8710 
 
H -2.5205 -1.9643 -2.3196 
 
 -2.8467 -0.0507 -1.2793 
 
 -3.6222 -0.6299 -0.7375 
 
 -0.4990 -2.7317 -2.2377 
  1.4876 -1.7862 -2.1031 
H  2.0448 .1971 -2.8670 
H  1.8345 .8309 -2.2491 
  2.0020 -1.3350 -0.7311 
C  1.7028 .1981 -0.0220 
C  0.7905 .9997 -0.2037 
O  1.1579 .0203  0.3888 
C -1.3122 -3.3735 
H -2.3859 -3.1124 
H -1.0046 -3.2507 
C
H
C -1.7409  0.3329 -0.2683 
 
H
 
C
 
-1
 
-2
 
C
 
-0
 
 0
 
 2
 
 1.6909 
 
 1.6341 
 
 2.7524 
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H -1.2124  1.4342 -4.4518 
 
C  1.0373  1.1320 -3.0334 
 
H  1.8671  0.7100 -2.4366 
 
H  1.1607  0.8046 -4.0891 
 
H  1.1703  2.2355 -3.0041 
 
C  3.0744 -2.2800 -0.2224 
 
H  3.5066 -1.9993  0.7573 
 
H  2.6471 -3.3049 -0.1260 
 
H  3.9071 -2.3551 -0.9606 
 
C  2.5516  0.0956  1.2128 
 
O  2.2122 -0.0998  2.3661 
 
O  3.7614  0.5973  0.8639 
 
C  4.5994  0.9959  1.9596 
 
H  4.1026  1.7900  2.5568 
 
H  4.8210  0.1343  2.6263 
 
H  5.5308  1.3817  1.5009 
 
O -2.2181  1.2713  0.6916 
 
O -1.3692 -0.8861  0.3740 
 
C -3.0515  0.6957  1.7001 
 
H -3.9388  0.2014  1.2372 
 
H -3.4223  1.5574  2.2940 
 
C -2.2666 -0.3147  2.5939 
 
C -1.0314 -0.7366  1.7583 
 
H -0.6491 -1.7279  2.0780 
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H -0.2047 -0.0072  1.8980 
 
C -1.7855  0.3573  3.8940 
 
H -2.6452  0.6192  4.5520 
 
H -1.1110 -0.3158  4.4698 
 
H -1.2200  1.2898  3.6730 
 
C -3.1570 -1.5320  2.9050 
 
H -3.4024 -2.0899  1.9735 
 
H -2.6451 -2.2347  3.6007 
 
H -4.1149 -1.2236  3.3832 
 
H -3.3238  0.8914 -1.6179 
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